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ABSTRACT 
 Health benefits from consuming rice bran oil (RBO) have been extensively studied in 
humans.  RBO has been shown to decrease cholesterol absorption by inhibiting the oxidation of 
the LDL-cholesterol.  γ-Oryzanol is one of the RBO components that possess antioxidative 
properties; it is a polyphenolic compound resembling tocopherol (vitamin E), which is another 
component of RBO.  There are evidences that oryzanol has potential applications for enhancing 
shelf-life of foods containing fats processed at a high temperature, decreasing the total 
cholesterol, LDL-cholesterol and triglyceride levels in plasma lipids, and healing ulcers.  In order 
to take advantage of the health benefits of oryzanol, food products fortified with oryzanol should 
be developed and characterized.  Cheddar cheese containing γ-Oryzanol was developed, and the 
effects of oryzanol on cheese quality during ripening process were studied.  Cheese was stored 
for 5 months and drawn every month for quality evaluation of color, texture, microbial growth, 
aroma development, bacterial identification by polymerase chain reaction, oryzanol retention, 
moisture content and free fatty acid profile.  The consumer acceptance was evaluated after 5 
months of maturation.  The results indicated that by adding γ-Oryzanol to cheddar cheese 
changes occurred in the quality, but, they were not significant when stored for up to 4 months, 
and the γ-Oryzanol was well retained.  Consumers were able to differentiate the cheddar cheese 
containing γ-Oryzanol from the control containing no γ-Oryzanol.  Overall appearance, texture, 
taste and hardness were the most discriminatory sensory attributes.  There was a significant 
positive increase 0.13 to 0.30 times higher in the purchase intent of cheddar cheese containing γ-
Oryzanol after consumers had been informed about the health benefits of oryzanol.  Overall 
liking was the attribute critical to purchase intent and the most important attribute that changed 
the acceptability of the cheese.  Consumers preferred the cheese with γ-Oryzanol less than the 
 xv
control but were willing to buy it and compromise the overall liking of cheese merely to get the 
health benefits of the product.  Further studies need to be done to determine the direct effects of 
cheddar cheese containing γ-Oryzanol in human health, and to optimize the homogenization and 
fortification of γ-Oryzanol when incorporated in cheese products. 
 
 
 
 1
CHAPTER 1. INTRODUCTION 
 The functional foods industry is evolving at a rapid pace.  Consumer interest in healthy 
eating and self-medication is not just a passing fad.  The growing importance of health and 
wellness has significantly altered consumption and buying behaviors.  In the United States and 
some other developed countries, functional and/or nutraceutical foods have already become part 
of consumers’ regular diet as exemplified in the rush of energy bars, meal replacement beverages 
and fortified cereals, vitamin/mineral supplements, herbal extracts, etc.  The global market for 
functional foods is estimated to be over $45 billion in 2002 (Institute of Food Technologists 
Functional Foods Newsletter, 2002).  Nowadays consumers are more health-conscious and often 
search for health foods as part of their daily diets; this drastically alters their consumption and 
buying behaviors.  Consumers also pay attention to the link between diet and health. 
 Health benefits from consuming rice bran oil (RBO) have been extensively studied in 
humans.  RBO has been shown to decrease cholesterol absorption by inhibiting the oxidation of 
the LDL-cholesterol.  γ-Oryzanol is one of the RBO components that possess antioxidative 
properties; it is a polyphenolic compound resembling tocopherol (vitamin E), which is another 
component of RBO (Godber et al., 2002).   
γ-Oryzanol has not been thoroughly investigated as a functional ingredient in food 
products, but its potential applications in human health such as antioxidant activity, reduction of 
serum cholesterol, cholesterol absorption as well as of early atherosclerosis risk, inhibition on 
platelet aggregation, inhibition of tumor promotion, menopausal syndrome treatment and 
antiulcerogenic activity have been thoroughly investigated. 
 In order to take advantages of the health benefits of γ-Oryzanol, food products fortified or 
enriched with γ-Oryzanol should be developed as functional foods that may interest consumers. 
 2
 The natural cheese consumption per capita in the U.S. increased almost 2% from 2001 to 
2002.  More impressively, during the last quarter of the 20th century, when fluid milk 
consumption was rapidly declining, cheese consumption continued to grow.  According to the 
2003 HealthFocus® Trend Report, use of full-fat cheese is on the rise, but coming at the expense 
of low-fat, fat-free, lower-cholesterol and lower-calorie alternatives. 
 Usual value-added cheese have the addition of herbs, chopped nuts or seeds such as 
caraway to the curds of lightly flavored soft cheese.  Hard and semi-hard cheeses are, in general, 
less suitable for development of value-added variants.  Cheddar is the most popular cheese flavor 
in North America (Spanier et al., 2001).  It is by far the most important variety of hard cheese 
and is produced on an extremely large scale and on a world-wide basis (Varman and Sutherland, 
2001).  In addition, cheddar cheese should be a compatible food matrix with γ-Oryzanol because 
it contains the highest amounts of tocopherols (vitamin E) compared with other hard cheeses 
which scarcely contain vitamin E (Renner, 1989). 
 Knowing that cheddar cheese is a very acceptable and well-liked product on a world-
wide basis and that it is compatible with the characteristics of γ-Oryzanol, a sharp cheddar 
cheese containing γ-Oryzanol was developed in the Dairy Store of the Department of Dairy 
Science at Louisiana State University, and the effects of γ-Oryzanol on its quality were studied 
during the 5-month ripening process which had not been done before. 
 The developed cheese was stored for up to 5 months and drawn for quality evaluation 
every month.  The quality parameters evaluated in the cheese included color, texture, microbial 
growth, aroma development, bacterial identification by polymerase chain reaction, oryzanol 
retention, moisture content and free fatty acid profile together with consumer acceptance after 5 
months of maturation. 
 3
 In this thesis, first, a literature review (Chapter 2) is presented, including background 
information related to the topic, such as RBO, health benefits of γ-Oryzanol, cheddar cheese, its 
characteristics and manufacturing procedures, functional foods, cheese trends and a brief 
discussion of the research justifications.  The materials and methods (Chapter 3) are extensively 
described with information related to each procedure, including the physicochemical and 
biological analyses, the consumer study design and the statistical analysis.  The results and 
discussion (Chapter 4) of every quality parameter evaluated in this research are presented.  The 
conclusions are presented in Chapter 5.  The last section includes the appendices containing 
some figures, the consent form for the consumer study, the questionnaire used for the consumer 
study and SAS codes used for the statistical analysis of all experiments.  
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CHAPTER 2. LITERATURE REVIEW 
2.1 Rice Bran Oil and γ-Oryzanol 
 Rice Bran Oil (RBO) is made from the pericarp and germ of the Oryza sativa seeds.  Rice 
bran constitutes about 10% of rough rice grain and contains 18%-22% oil.  RBO contains a small 
variable quantity of tocotrienols (72-612 ppm, especially β- and γ-tocotrienols) (Rukmini and 
Raghuram, 1991; Rogers et al., 1993).  Moreover, RBO is naturally very rich in α-tocopherol 
(ca. 100 mg), similar to soybean oil, another vegetable oil with a well-known 
antihyperlipidaemic action (Changbumrung et al., 1980). 
In contrast to most common refined vegetable oils, crude rice bran oil is richer in 
unsaponifiable matters such as steryl ferulates which have growth-promoting vitamin-like 
activity.  Steryl ferulates consist of a mixture of esters of ferulic acid with plant sterol or 
triterpene alcohol, which are unique to rice oil, with important pharmacological actions 
(Jariwalla, 2001).  The prototype member of the group is γ-Oryzanol, which has been extensively 
characterized and studied (Naruse and Takeshita, 1999) and was first isolated by Kaneko and 
Tsuchiya in the early 1950s (Kaneko and Tsuchiya, 1955). 
The most accessible natural source of γ-Oryzanol is rice bran, but some components of γ-
Oryzanol, mainly sitostanyl ferulate and campestanyl ferulate and lesser amounts of sitosteryl 
ferulate and campesteryl ferulate, can also be found mostly in the inner pericarp of corn, wheat, 
rye and triticale grains (Seitz, 1989). 
2.1.1 Properties of γ-Oryzanol 
   γ-Oryzanol is a mixture of ferulic acid esters of triterpene alcohols such as cycloartenol 
and 24-methylene cycloartanyl (Figure 2.1), and about 1 to 3% is found in RBO.  Its 
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fundamental molecular structure is the ferulic acid aromatic phenolic nucleus esterified to 
cyclopentanperihydrophenanthrene (Seetharamaiah and Prabhakar, 1986). 
 Gamma-oryzanol is a white or slightly yellowish, tasteless powder with little or no odor 
(O’Neil et al., 2001), and its industrial production is shown in the flowchart of Figure 2.2. 
Figure 2.1:  Oryzanol comprises any of several plant sterols esterified to ferulic acids.  The 
example shown here is cycloartenyl ferulate. 
 
Figure 2.2:  Production flowchart of gamma-oryzanol. 
 RBO and its main components are non-toxic and non carcinogenic (Deckere and Korver, 
1996), and the γ-Oryzanol molecule may be poorly absorbed after oral administration 
(Scavariello and Arellano, 1998).  Used commercially in Japan as a food, γ-Oryzanol protects 
Raw material: rice bran or rice germ 
Extraction 
Rice Bran or Rice Germ Oil 
Crude Rice Oil 
Refining 
Refined oil Soaps 
Distillation 
Recrystallization 
Drying 
Sterilization 
γ-Oryzanol 
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RBO from oxidation and inhibits peroxidation of lipids medicated by iron or UV irradiation.  γ-
Oryzanol is a polyphenolic compound with hydroxyl groups and resembles tocopherol (vitamin 
E) in its antioxidant properties.  However, unlike tocopherol, it can increase the antioxidative 
ability of rice in a dose-dependent manner, at the same time manifesting resistance to high 
temperature (Jariwalla, 2001).  Additionally, the antioxidant capacity of γ-Oryzanol is enhanced 
in a synergistic manner in the presence of α-tocopherol and other amino acids (Jariwalla, 2001). 
2.1.2 Health Benefits of γ-Oryzanol 
 One of the most investigated properties of γ-Oryzanol is its antiulcerogenic property 
(Mizuta et al., 1978; Ichimaru et al., 1984).  Different studies have been carried out on rat 
models to evaluate which pharmacological mechanism is mainly involved in γ-Oryzanols'  
antiulcerogenic property.  One study investigated the antiulcerogenic effect of γ-Oryzanol in 
mice subjected to conditioned emotional stimuli (communication box method) and rapid eye 
movement (REM) sleep deprivations (flower pot method).  The incidence of gastric lesions was 
reduced by a single administration of γ-Oryzanol at 100 and 200 mg/kg. 
 γ-Oryzanol has also found an application as a medical antioxidant when used in 
combination with α-tocopherol.  Although γ-Oryzanol is widely employed in the cosmetic 
industry as an antioxidant, only one scientific study is available in the literature concerning its 
modulating effect on sebaceous gland secretion after the topical application (Ueda et al., 1976).  
Moreover, γ-Oryzanol is widely employed as an anabolic agent by bodybuilding athletes 
(Rosenbloom et al., 1992; Grunewald and Bailey, 1993). 
 When γ-Oryzanol (300mg/day) was administered for 3 months to hyperlipidaemic 
subjects, a significant decrease in plasma level of total cholesterol (TC) and low density 
lipoprotein cholesterol (LDL-C) was observed in both hypercholesterolaemic and 
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hypertriglyceridaemic patients, while a relevant increase in high density lipoprotein cholesterol 
(HDL-C) was observed only in the hypercholesterolaemic group, and no side effects were 
observed (Raghuram et al., 1989; Cicero and Gaddi, 2001; Yoshino et al., 1989a; 1989b).  
Similar results were obtained when chronic schizophrenic patients with dyslipidaemic who had 
been receiving neuroleptics for a mean of 10 years were treated with 100 mg of γ-Oryzanol three 
times daily for 16 weeks (Sasaki et al., 1990), and also when postmenopausal women having a 
diet enriched with test oils having γ-Oryzanol  (Lichtenstein et al., 1994). 
 A decrease in early atherosclerosis and reduction of cholesterol absorption were  
observed by Rong et al. (1997).  Research investigating the influence of oryzanol on platelet 
aggregation in rats concluded that oryzanol inhibited the aggregation (Seetharamaiah et al., 
1990). 
  Nair et al. (1984) concluded that RBO and γ-Oryzanol contribute to lowering the risk for 
colon cancer in humans.  Yasukawa et al. (1998) reported that γ-Oryzanol and its four major 
components (cycloartenyl ferulate, 24-methylene cycloartanyl ferulate, campesteryl ferulate and 
sitosteryl ferulate) had an inhibitory effect on tumor in two-staged carcinogenesis in mouse skin.  
In similar studies, the modifying effects of phytic acid and γ-Oryzanol on the promotion stage of 
carcinogenesis were investigated using several two-stage carcinogenesis models in rats.  The 
female rats were pretreated with a single intragastric dose of 7,12-dimethylbenz(a)anthracene 
(DMBA).  There were no significant differences in the final incidences and multiplicities of 
mammary tumors; the average tumor diameter was significantly reduced, and the average 
survival time was increased with phytic acid and γ-Oryzanol but without significant difference 
(Hirose et al., 1999).  These results indicate that phytic acid inhibits hepatic and mammary 
carcinogenesis. 
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A water-soluble oryzanol enzymatic extract (WSOEE) was developed recently and 
evaluated for its antioxidant potential.  WSOEE has been shown to have the in vitro antioxidant 
capacity due to the extensive scavenging of peroxyl radicals.  WSOEE is a new potential 
antioxidant agent from rice bran, being a new source of water-soluble oryzanol.  This soluble 
product showed a high free-radical-scavenging capacity, preventing protein oxidation and lipid 
peroxidation when cells ex vivo were exposed to active-oxygen substances and/or free radicals.  
This property makes it potentially useful in the formulation of solid and liquid food for treatment 
and prevention of chronic pathological states associated with a high generation of active-oxygen 
substances and/or free radicals – such as atherosclerosis, neurodegeneration, and cancer – and for 
elderly persons and practitioners of sports (Parrado et al., 2003). 
The effect of high oryzanol RBO on the oxidative stability of low-heat and high-heat 
whole milk powder (WMP) was investigated by Nanua et al., 2000.  The results from this study 
indicated that RBO has potential for use as a natural antioxidant in WMP, due to the presence of 
tocopherols and tocotrienols as part of the unsaponifiable matter, which have well-studied 
antioxidative properties. 
Antioxidant activities of vitamin E and γ-Oryzanol components purified from rice bran 
were studied in a cholesterol oxidation system accelerated by 2,2’-azobis(2-
methylpropionamidine) dihydrochloride, and all components exhibited significant antioxidant 
activity in the inhibition of cholesterol oxidation (Xu et al., 2001). 
2.1.3 Applications of γ-Oryzanol 
 γ-Oryzanol has suggested to have potential functionality such as antioxidant activity, 
reduction of serum cholesterol, reduction of cholesterol absorption and decrease of early 
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atherosclerosis, inhibition on platelet aggregation, inhibition of tumor promotion, menopausal 
syndrome treatment and antiulcerogenic activity. 
 Since the functionality of γ-Oryzanol is promising, rice bran or γ-Oryzanol may have 
great market potential and can be applied to a wide range of products and functional foods that 
may provide cholesterol-lowering and antioxidant effects. 
2.2 Cheese 
 The word “cheese” is commonly used as a collective term for widely variable products 
such as matured and non-matured cheese made with rennet, acid curd cheese, fresh cheese, and 
even processed cheese.  Most of these fit the definition established by the FAO/WHO, i.e.,  
cheese is the fresh or matured solid or semi-solid product obtained by coagulating milk, 
skimmed milk, partly skimmed milk, cream, whey cream, or buttermilk, or any combination of 
these materials, through the action of rennet or other suitable coagulation agents, and by partially 
draining the whey resulting from such coagulation. 
2.2.1 Cheese Principles 
 Cheese manufacturing is aimed at making an attractive and durable product in which 
important nutrients of the milk are concentrated.  The cheese must be left to ripen to acquire 
desirable flavor and consistency.  To achieve this, cheese is kept for a variable time under 
favorable conditions.  Cheese making is a complicated process, involving many processing steps 
and several biochemical transformations.  All of these variables affect yield, composition, and 
quality of the cheese and its byproducts (predominantly whey), and often in different directions 
(Walstra et al., 1999). 
 When milk is made into cheese, casein and fat are concentrated, whereas the other milk 
components, especially water, are mainly removed along with whey.  None of the milk 
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components are fully retained, and other substances may be added, notably salt.  This is 
illustrated in Figure 2.3.  The yield and the composition of the cheese are determined by the 
properties of the milk, especially composition, and by the manufacturing practice. 
 
Figure 2.3:  Example of the gross composition of milk and cheese and of the transfer of 
components from milk to cheese (Walstra et al., 1999). 
 
 The manufacture of cheese may involve many different processing steps, where some 
steps are essential for all cheese varieties: (1) clotting of the milk by means of enzymes or acid, 
or both (a gel is formed, due to the casein particles aggregating into a network, enclosing fat 
globules), (2) removal of whey (comparable to milk serum) by means of syneresis of the gel (the 
resulting curd makes up 10% to 30% of the original volume of milk; the drier the curd, the firmer 
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and the more durable the cheese will be), (3) acid production in the cheese during its 
manufacture due to the conversion of lactose into lactic acid by lactic acid bacteria (the resulting 
pH of curd and cheese affects such parameters as syneresis, consistency, and ripening of the 
cheese), (4) salting, (5) fusion of curd grains into a coherent loaf that is easy to handle, and (6) 
ripening (microbial, biochemical, chemical, and physical processes during ripening are 
responsible for changes in composition and structure of the cheese; hence flavor and texture). 
 Fusion of curd grains and ripening are typical processing steps of ripened cheese; when 
these are not carried out, the product is referred to as fresh cheese (Walstra et al., 1999). 
 With the objective of diminishing variation in the course of the manufacture of the cheese 
and in its properties, some additional process steps have been applied: pasteurization of the milk 
and addition of cultures of microorganisms to the milk. 
 By using different biochemical processes, the relatively tasteless dairy protein is 
converted into tasty and easily digestible cheese with different flavors.  Cheese is rich in 
essential amino acids and it also binds large amounts of minerals and vitamins (Spreer and Mixa, 
1998). 
 Worldwide, there are more than 2000 types of cheese, sometimes made by very different 
manufacturing processes.  A classification can be based on several aspects, and is done in 
different countries according to different criteria.  A general classification can be made for three 
major groups: rennet or natural cheese, fresh cheese or non ripened cheese and long-life cheese 
(processed cheese).  For another classification into groups and types, different aspects and 
characteristics can be used, such as: type of process (rennet cheese, rennet acid cheese, acid curd 
cheese, processed cheese), type of consistency (hard, semi hard, semi soft, soft cheese), type of 
milk (cow, sheep, goat, buffalo), chemical composition (Calcium content in conjunction with 
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pH, dry matter, water, fat), ripening process (ripened cheese and non ripened/fresh cheese), 
variations in taste, type of hole formation (large, medium and small round holes, cracks, irregular 
holes, no holes) and surface characteristics (blue fungus or white fungus cheese, smear cheese, 
skinless cheese).  A general and internationally recognized classification is based on the raw 
material, type of consistency, interior and exterior, interior hole formation and surface 
characteristics (Spreer and Mixa, 1998). 
2.2.2 Cheddar Cheese Properties 
 Cheddar-type cheeses are characterized by the mixing of salt with the curd before 
pressing it into a coherent loaf.  Salt considerably retards the growth of lactic acid bacteria.  
Because of this, most of the lactose in the curd should have been converted before the curd is 
salted.  Moreover, salted curd tends to fuse poorly during pressing if its pH is still too high 
because the curd flows insufficiently (Walstra et al., 1999). 
 Cheddar cheese is classified as a hard cheese, with a long shelf life and without a surface 
flora.  It is about 45% to 50% fat in the dry matter and minimum dry matter of 62% (Spreer and 
Mixa, 1998).  It has a buttery but firm body with close texture and a clean nutty flavor (Varnam 
and Sutherland, 2001). 
 Cheddar cheese contains little active milk proteinase, active rennet, and a large pool of 
proteolytic enzymes from lactic acid bacteria; most of the fast acid-producing strains are also 
strongly proteolytic.  At the low curing temperature (usually below 10°C) the proteolysis in the 
depth is relatively slow, whereas the degradation in the width is fast.  It may be cured for varying 
lengths of time, from 3 to 15 months (Early, 1992).  The curing room is around 85% percent 
relative humidity at 4°C (40°F) and the cheese is held for 60 days or longer.  The peak flavor is 
usually attained in 9 to 12 months (Kosikowski and Mistry, 1997). 
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Defects that may occur in Cheddar cheese include: open texture which may lead to 
formation of cracks upon gas production during maturation, “seaminess” which refers to the 
appearance of whitish “veins” seen in a cross-section of the cheese, incomplete acid production  
that often is responsible for insufficient flavor and abnormal consistency, contaminating bacteria 
that may cause defects, especially at high pH, low salt content, and high ripening temperature, 
difficulties in cooling down the interior of the cheese when made in very large blocks, and bitter 
flavor development if the salt content is low and the curing temperature is high (Walstra et al., 
1999). 
2.2.3 Cheddar Cheese Manufacture 
 A big demand is put on the starter culture.  The curd making should be as brief as 
possible for economical reasons, and this requires very fast acid production.  Therefore, fast-
growing, fast acid-producing and phage-resistant bacteria are needed.  This combination is hard 
to fulfill; for that reason, mixtures of single-strain, fat starters are generally employed, and 
contamination of the starter by phages is rigorously prevented.  Furthermore, the starter should 
be homofermentative (little gas production), and cause no bitterness in the cheese.  Strains of 
Lactococcus lactis var. cremoris are usually used.  Currently, a mixture of two strains 
(Lactococcus lactis subsp. cremoris and subsp. lactis) is often applied, e.g., in a ratio of 1:2 
(Walstra et al., 1999).  The former strain is fairly heat-tolerant (i.e., it keeps growing during 
scalding) and is responsible for a fast acid production; however, these bacteria form many bitter 
peptides which are decomposed poorly.  The second strain is far less heat-tolerant (it does 
produce some acid during scalding, but it does not keep growing, and hence contributes little to 
the rate and extent of acid production), but has considerable “debittering” properties while not 
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producing many bitter peptides itself; hence, the proteolytic system of these bacteria is of great 
importance for a satisfactory maturation (Walstra et al., 1999). 
 Figure 2.4 outlines the manufacturing process of cheddar cheese.  It represents a 
somewhat traditional way of manufacturing, although formerly the time from renneting to 
milling often was even much longer.  Nowadays a fixed time schedule is usually maintained and 
the processing time is much shorter, e.g., 3 hours from renneting to milling. 
 After cutting, stirring and scalding, the curd settles and fuses into a rather compact mass.  
Then “cheddaring” starts, which is a process, characteristic of Cheddar and of most of its related 
types.  The whey is drained off, and the curd mass cut into large strips that are piled up.  The 
slabs fuse again and are allowed to spread slowly into thinner slabs that are turned, cut again into 
strips, piled up, etc. 
 The curd mass will only flow readily if its pH is lower than 5.8 and the temperature is not 
too low.  The flow causes a “fibrous” curd structure.  It has long been assumed to be essential for 
obtaining a characteristic Cheddar. 
 Paramount is the acid production during cheddaring.  The water content and pH of the 
curd at that stage largely determine the composition of the cheese.  The curd is pressed into a 
loaf when its acidity is low. 
 Prior to salting, the curd is milled, i.e., cut into strips about the size of a finger.  Milling 
too finely leads to excessive loss of fat and curd fines in the press whey.  Milling too coarsely 
causes a longer time for the diffusion of the salt into the strips to complete, resulting in a non 
homogeneous cheese texture.  The salt is mixed with the curd and some time is allowed for salt 
absorption (mellowing); otherwise, excessive salt would be lost with the whey, which in normal 
cases already contains about 50% of the added salt (both milling and pressing cause a 
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considerable expulsion of whey).  The salt should be evenly distributed, but this is hard to 
achieve.  Acid production in the curd is insufficient if the cheese contains over 5% to 5.5% salt 
in the water, while at less than 4.5% salt the lactic acid bacteria ferment too fast.  In either case 
the flavor development is unsatisfactory and contaminating organisms have a greater chance of 
growing out, which may cause strong off-flavors (Walstra et al., 1999). 
 
Figure 2.4:  An example of a traditional method for manufacture of Cheddar cheese. Simplified 
from Walstra et al. (1999). 
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 The curd, after salting, is usually pressed under vacuum and lower pressure.  The lower 
the temperature and the pH during pressing, the more difficult it is to transform the salted curd 
into a coherent loaf.  Soon after pressing, the cheese (often in the shape of large blocks) is 
supplied with a surface coating (e.g., paraffin), after which it needs little further care; but it is 
also common to find processors making rindless cheddar cheese (Kosikowski and Mistry, 1997). 
2.3 Functional Foods 
2.3.1 Definitions 
 Japan is the birthplace of the term “functional foods”.  The term “Foods for Specific 
Health Use (FOSHU)” was established in 1991 after large-scale research programs were 
launched and funded by the Japanese government in the early 1980s on systematic analysis and 
development of food functions, analysis of physiological regulation of the function of food and 
analysis of functional foods and molecular design (Ashwell, 2002). Afterwards, a variety of 
terms, more or less related to FOSHU have appeared world-wide.  These include more exotic 
terms, such as nutraceuticals, designer foods, pharmafoods, medifoods, vitafoods and the more 
traditional dietary supplements and fortified foods.  All are foods or food products marketed with 
the message of a benefit to health. 
The term “nutraceutical” was coined from “nutrition” and “pharmaceutical” by Stephen 
DeFelice, founder of Foundation for Innovation in Medicine, in 1989.  He defined a nutraceutical 
as a food, dietary supplement, or medical food that has a medical or health benefit, including the 
prevention and treatment of disease (DeFelice, 1995). 
 For FDA, functional foods can fall into a number of existing categories of the Federal 
Food, Drug and Cosmetic Act of 1938 (FDCA), as amended.  If the product is determined to be a 
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food and not a drug, it can be regulated as conventional food (including food for special dietary 
use), dietary supplements, medical food, or as infant formulas. 
 In Canada, two definitions emerged.  A nutraceutical is a product isolated or purified 
from foods that is generally sold in medicinal forms not usually associated with food.  A 
nutraceutical is demonstrated to have a physiological benefit or provide protection against 
chronic diseases.  A functional food is similar in appearance to, or may be, a conventional food, 
is consumed as part of a usual diet, and is demonstrated to have physiological benefits and/or 
reduce the risk of chronic disease beyond basic nutritional functions (Dentali, 2002). 
 The European Commission (EC) Concerted Action known as FUFOSE (Functional Food 
Science in Europe) states that a food can be regarded as functional if it is satisfactorily 
demonstrated to affect beneficially one or more target functions in the body, beyond adequate 
nutritional effects, in a way that is relevant to either an improved state of health and well-being 
and/or reduction of risk of disease.  Functional foods must remain foods, and they must 
demonstrate their effects in amounts that can normally be expected to be consumed in the diet.  
They are not pills or capsules, but part of a normal food pattern (Ashwell, 2002). 
 Since 1989, the nutraceutical or functional food industry has evolved into a market worth 
$20.2 billion in the U.S. and a global market estimated to be $47.6 billion in 2002 (Institute of 
Food Technologists Functional Foods Newsletter, 2002). 
 According to a Business Communications Co., Inc. report, the nutraceuticals market’s 
growth is attributed to different factors: consumers have an increasing interest in maintaining 
better health, there has been a rise in available information regarding the link between diet and 
health, many consumers wish to avoid spending money on health care and prescription 
medications, there have been several changes in food laws that have affected label and product 
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claims and an increasing sector of the public is quickly aging and purchasing functional food 
products (Business Communications Co., Inc., 2003).  This report clearly shows that there is a 
real gap to introduce more functional foods in the U.S. market, and consumers will be interested 
in them. 
2.3.2 Cheese Trends 
 The growing importance of health and wellness has significantly altered consumption and 
buying behaviors.  Low-carbs diets, concerns about trans-fat and obesity, and greater demand for 
organic and natural products are requiring a shift in what it is marketed and how it is marketed.  
The consumer demand for convenience has always been a driving factor in the food industry.  
But as the pace of life quickens, consumer expectations continue to rise, whether it’s for ease of 
preparation, greater portability or the convenience of single-serve packages. 
 Consumers learned during the 1990s that, for the most part, to enjoy cheese they could 
not cut back on fat grams.  In fact, when most consumers choose cheese, they are not too worried 
about the Nutrition Facts label, the emphasis is on flavor (Berry, 2004). 
 The natural cheese consumption per capita in the U.S. increased almost 2% from 2001 to 
2002.  More impressively, during the last quarter of the 20th century, when fluid milk 
consumption was rapidly declining, cheese consumption continued to grow.  In fact, since 1980, 
consumption of natural cheese per capita has increased roughly 75% (USDA/ERS, 2003) and 
about 60% for cheddar cheese (USDA/ERS, 2004). 
 According to the 2003 HealthFocus® Trend Report, use of full-fat cheese is on the rise, 
but coming at the expense of low-fat, fat-free, lower-cholesterol and lower-calorie alternatives.  
In 2002, only 26% of shoppers used low-fat, low-cholesterol or low-calorie cheese weekly, down 
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19 points from 45% in 1994.  Use of regular or full-fat cheese was 61%, up 8 points from 53% in 
1994.  Use of fat-free cheese, which has only been tracked since 2000, was down 2 points. 
 Cheesemakers continue to be innovative in the range of flavors added to cheese.  They 
are taking natural cheese favorites and giving them exciting new flavor profiles, Havarti, for 
instance, is now available with horseradish and chives, Cheddar is spiked with Pinot Grigio or 
Shiraz, and Smoked Gouda is enhanced with garlic (Berry, 2004).  Convenience is another trend 
that continues on an upward trajectory. 
 Cheddar and Hispanic-style cheeses are the most preferred cheeses on burritos and 
quesadillas, with almost three-fourths of all consumers preferring multiple cheeses on these 
Mexican foods.  Indeed, the popularity of Hispanic foods, along with Hispanic cheeses, is at an 
all-time high.  Manchego, asadero, queso blanco, all Hispanic cheeses, promise to become as 
familiar to the U.S. consumer as Cheddar and Mozzarella. 
 Though still a relatively small niche, organic dairy products, including cheeses, are 
among the fastest growing food categories.  Consumer demand for products perceived to be 
healthful and natural is fueling the trend, as is cheesemaker and dairy producer interest in reaping 
the often significantly higher margins that organic products command. 
 Vitamin D is important in human bone health.  Leading public health experts are getting 
concerned that the general population is not getting enough vitamin D as a result of decreased 
consumption of milk and increased used of sunblock (the body makes vitamin D when 
unprotected skin is exposed to sunlight).  Researchers at the Minnesota-South Dakota Dairy 
Foods Research Center, St. Paul, Minn., have successfully fortified pasteurized processed cheese 
with vitamin D3 (100 IU per serving).  There was no loss of vitamin D3 during manufacturing, 
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and the vitamin was uniformly distributed.  No loss of the vitamin occurred during storage over a 
nine-month period (Lovette, 2004).  
 Recent media attention surrounding cholesterol created a new market for dairy products 
that work to reduce the level of low-density lipoproteins (LDL) levels found in the body.  
Glanbia Dairies (Dublin, Ireland) introduced an innovative product in the United Kingdom called 
Heartily Healthy cholesterol-reducing cheese alternative.  Since cheese products typically 
contain high levels of cholesterol, the company states that the Cheddar-style product is made 
using milk that has had the dairy fat replaced with wheat germ oil-–an ingredient known to 
combat cholesterol (Kuhn, 2004). 
2.4 Research Justifications 
 γ-Oryzanol utilization, as a functional ingredient, has not been thoroughly investigated.  
Its potential applications in human health such as antioxidant activity, reduction of serum 
cholesterol, cholesterol absorption and risk of early atherosclerosis, inhibition on platelet 
aggregation, inhibition of tumor promotion, menopausal syndrome treatment and antiulcerogenic 
activity, are excellent reasons to take advantage of the health benefits of γ-Oryzanol 
consumption.  In order to take advantage of these benefits, food products fortified or enriched 
with γ-Oryzanol should be developed as functional foods that may interest consumers. 
 In order to find the best food product fitting the potential functionalities of γ-Oryzanol, its 
properties must be taken into account.  γ-Oryzanol is liposoluble, and its antioxidant activity is 
enhanced synergistically in the presence of α-tocopherol as described in section 2.1.1. 
 A product which delights the taste of a big percentage of the population and is healthy by 
itself is a good potential target, regardless of race, religion, background or social stratus.  Hard 
cheeses contain high amounts of fat, are an excellent source of Calcium for lactose intolerant 
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people, and also contain proteins with essential aminoacids necessary for a normal body 
metabolism.  Hard cheeses also contain microorganisms which benefit human intestinal flora.  
Adding a nutritive value to a hard cheese with health benefits creates consumer awareness of the 
functional cheese products. 
 Several studies suggest that dairy foods such as cheese and milk prevent demineralization 
of enamel and favor remineralization related with dental caries.  Silva et al. (1986) using 
intraoral caries models (i.e., models that use sections of human or bovine enamel placed at 
interproximal sites in fixed appliances), found that consumption of 5 g of aged Cheddar cheese 
immediately following sucrose intake (i.e., a 10 percent sucrose challenge) reduced, by an 
average of 71%, sucrose-induced demineralization of experimental enamel slabs.  Likewise, 
using a new in situ caries model developed by Featherstone and Zero (1992), enamel 
demineralization occurred in the absence of Cheddar cheese.  In contrast, in the presence of 
cheese, a significant trend toward remineralization of enamel was evident.  In addition, 
components in cheese or milk such as protein (casein and whey), lipids, calcium, and phosphorus 
may be partly responsible for the beneficial effects of these foods on oral health (Miller et al., 
1995). 
 Cheddar is the most popular cheese flavor in North America (Spanier et al., 2001); it is 
by far the most important variety of hard cheese and is produced on an extremely large-scale and 
on a world-wide basis (Varnam and Sutherland, 2001).  In addition, cheddar cheese shows a 
compatible food matrix with γ-Oryzanol because it contains the highest amount of tocopherols 
(vitamin E) compared to other hard cheeses which scarcely contain vitamin E (Renner, 1989), 
and thus its antioxidant effects can be enhanced.   
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In a search performed in Medline (PubMed), in Agricola and in Ingenta with key words 
combining “rice bran oil”, “RBO”, “oryzanol”, “gamma-oryzanol”, “γ-oryzanol”, “nutraceutical” 
or “functional” with “cheese”, it could be noticed that there has not been any research on cheese 
containing RBO components or γ-Oryzanol, nor or the possible effects of these compounds in 
the quality of the cheese.   
Usually value-added cheeses have had the addition of herbs, chopped nuts or seeds such 
as caraway to the curds of lightly flavored soft cheese.  Hard and semi-hard cheeses are, in 
general, less suitable for development of value-added variants.  Cheddar cheese and related 
cheeses, may, however, be supplemented with various materials including chopped walnuts and 
pickles.  Both hard and soft types are involved and may be blended with a range of beverages 
including beer, whisky, port wine and liqueurs (Varnam and Sutherland, 2001).  Nutritionally 
modified cheeses are mostly related with low-fat soft cheese varieties or hard cheeses using 
unmodified technology which lacks of the characteristic ripened flavor of the full fat equivalent 
and has bitter taste characteristics. 
With one in four Americans suffering from some form of coronary heart disease, 108 
million with high cholesterol levels, it is not surprising that almost every consumer behavior 
related to improving heart health has escalated (AHA, 2004).  Four out of ten of households 
(43%) are treating a member for high cholesterol (Sloan, 2004) and with 44% of shoppers saying 
that reducing the risk of heart disease or helping to maintain healthy cholesterol levels is an 
extremely/very important food claim.  Marketers have begun differentiating heart-healthy 
products based on their ingredients (HealthFocus®, 2003). 
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For all the reasons mentioned above, cheddar cheese containing γ-Oryzanol was 
developed, which could potentially have better positive effects in humans than other products 
with a different nutritional profile. 
2.5 Objectives 
2.5.1 General 
 The main goal of this study was to develop a sharp cheddar cheese containing γ-Oryzanol 
and study its effects on cheese quality during and after the ripening process. 
2.5.2 Specific 
 Determine quality differences of sharp cheddar cheese containing γ-Oryzanol by 
evaluating color, texture, microbial growth, aroma development, moisture content, free fatty acid 
profile, starter culture performance and the oryzanol retention together with a consumer study 
after 5 months of maturation. 
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CHAPTER 3. MATERIALS AND METHODS 
3.1 Cheddar Cheese Manufacturing 
 The process used to produce the cheddar cheese containing γ-Oryzanol was similar to the 
method shown in Figure 2.4 (section 2.2.3). 
 The facilities of the creamery in the Dairy Science department in the LSU campus were 
used to produce the cheddar cheese containing γ-Oryzanol. 
 Milk obtained from the LSU farm (6201 Lb) was pasteurized on October 28th, 2003 at 
177°F (77°C) for 20 seconds, then kept overnight below 40°F (4.5°C) until the next day for the 
cheese making.  The milk contained 3.46% of fat and 3.06 % of protein. 
On October 29th, 2003, early in the morning, the pasteurized milk was poured in a vat and 
heated slowly with constant stirring.  The heating process was continued by increasing the 
temperature at a rate of 1°F every 2 minutes for approximately 1.5 hours until the temperature 
reached 88°F (Figures 3.1 and 3.2). 
At this point, the starter culture, mesophilic direct vat set (DVS) from CHR Hansen 
(Milwaukee, WI) was added at 2.1% by weight (Figures 3.3 and 3.4), which contains selected 
strains of Lactococcus lactis subsp. cremoris and  subsp. lactis.  Together with the starter culture, 
the color (annatto food color) was added, at 0.03% by weight (Figures 3.5 and 3.6). 
 The milk with the starter culture and the color was stirred at 88°F for 45 minutes.   
Immediately afterward, calcium chloride food-grade (CaCl2 aqueous solution 32%) from DSM 
(DSM Food Specialties, Menomonee Falls, WI) was added at 0.02% w/v (Figure 3.7). 
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Figure 3.1:  Stirring milk in the vat while being heated up. 
 
 
Figure 3.2:  Stirring milk in the vat while being heated up before adding culture. 
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Figure 3.3:  Adding starter culture to milk when temperature reached 88°F. 
 
 
Figure 3.4:  Different view of the addition of the starter culture to the heated milk. 
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Figure 3.5:  Adding color to heated milk after starter culture was added. 
 
 
Figure 3.6:  Color added to heated milk while stirring. 
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Figure 3.7:  Addition of CaCl2 to the milk after the culture and color were added. 
 
 
Figure 3.8:  Adding the rennet into the milk after the culture, color and CaCl2 were added. 
 
 The process continued with agitation at 88°F for 15 minutes then the rennet from CHR 
Hansen (Milwaukee, WI) was added at 0.01% with a dilution 1/50 in water.  The rennet 
consisted of a 100% fermentation produced chymosin, Sodium Chloride (NaCl), Sodium 
Benzoate and caramel color.  The addition of CaCl2 and rennet is shown in the Figures 3.7 and 
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3.8, respectively.  The stirring was continued for a few seconds just to mix the rennet, then the 
agitation was stopped, and the milk was allowed to settle down for 35 minutes as the renneting 
took place.  Figure 3.9 shows that the vat was covered while the renneting process took place. 
 After 35 minutes, the hardness of the curd formed from the renneting process was 
checked to see if it was hard enough to start cutting (Figure 3.10).  As soon as the curds’ 
hardness was desirable, all the curd was cut as shown in Figures 3.11 and 3.12 and then was 
allowed to heal for 5 minutes.  The cutting process was done with extreme carefulness to avoid 
destroying the curd cubes since they are still fragile and soft. 
 
Figure 3.9:  Renneting taking place in the vat while the temperature was still 88°F. 
 
 Healing the curd can be observed in the Figure 3.13 where the curd was left undisturbed 
without agitation, and the cooking of the curd is shown in the Figure 3.14 when agitation was 
started again. 
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 The cooking process is also referred to as scalding which involves an increase of 
temperature from 88°F to 102°F at a rate of 3°F every five minutes with constant agitation.  The 
temperature was held at 102°F for about one hour. 
 
Figure 3.10:  Cutting the curd as a pre-test to check if it was hard enough to continue the 
process. 
 
 
Figure 3.11:  Cutting the curd after renneting. 
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Figure 3.12:  Another view of the process of cutting the curd after renneting. 
 
 
Figure 3.13:  The curd is healed by letting it sit without stirring. 
 
After letting the curd sediment to complete, the whey protein was drained out of the vat 
(Figures 3.15 and 3.16) while keeping the curd in the vat as shown in Figure 3.17. 
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Figure 3.14:  Cooking the curd with agitation and increasing the temperature. 
 
 To allow the whey protein to come out of the curd, the curd was cut in loaves (Figure 
3.18).  Then the loaves were separated as shown in Figure 3.19 and flipped over every 15 
minutes to facilitate the separation of the whey protein from the curd. 
 
Figure 3.15:  Draining of whey proteins out of the vat. 
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Figure 3.16:  Draining of whey protein, while keeping the curd inside vat. 
 
 
Figure 3.17:  Draining of whey protein, while keeping the curd inside vat (continued). 
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Figure 3.18:  Cutting curd into loaves of 20 inch long and 10 inch wide. 
 
 
Figure 3.19:  Flipping loaves over to help drain whey protein out of the curd. 
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Figure 3.20:  Two loaves of curd stacked to help release of whey protein in vat. 
 
 Stacking loaves over loaves increases pressure to release the whey protein still trapped in 
the curd, and flipping over also helps to drain whey protein.  Turning the loaves up side down 
took about 1.5 hours. 
The temperature of the vat was still kept at 88°F.  Once the titrable acidity reached 
0.45%, the loaves were no longer flipped over and subsequently were milled in pieces of 
approximately one inch by one inch by two to three inches (Figure 3.22).   
Once all the loaves were milled and spread over the surface of the vat, the curd was 
allowed to rest for 15 minutes, then salt was added at 2.8% w/w in 3 additions every 10 minutes 
and mixed (Figure 3.23). 
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Figure 3.21:  Four loaves of curd stacked to help release of whey protein in vat. 
 
 
Figure 3.22:  Milling the curd loaves into smaller pieces (1x1x2-3 inches). 
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Figure 3.23:  Mixing salt with the milled curd which lasted approximately 30 minutes. 
 
 At this point, a part of the salted curd was separated from the rest and the γ-Oryzanol 
(Maypro Industries, Inc., Purchase, NY) of 98.8% purity was added in amount to attain a 
concentration of 100mg per 28 grams of curd (see Appendix E for certificate of analysis of γ-
Oryzanol).  The mixing of γ-Oryzanol was done manually.  The salted curd without γ-Oryzanol 
was used as the control. 
 The curd was allowed to rest for about 10 minutes and then filled into a hoop of 40 
pounds having cheesecloth wrapped to avoid loss of curd during subsequent pressing (Figure 
3.24). 
 In the Figure 3.25, the pressing process using a pneumatic method can be seen where the 
curd was pressed and left overnight under a pressure of 50 psi. 
Following the overnight pressing step, the pressed curd was taken out of the hoops, 
separated from the cheesecloth and vacuum packed in plastic bags (Figure 3.26).   The plain curd 
(the control sample) and the curd containing γ-Oryzanol were packed separately.  After the curd 
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was packed in vacuum in plastic bags, the cheese is ready to be maturated in cold humid rooms 
for up to 5 months. 
 
Figure 3.24:  40 pound hoops with cheesecloth wrapping the salted curd. 
 
 
Figure 3.25:  Hoops filled with the curd pressed under 50 psi pressure overnight. 
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Figure 3.26:  Vacuum packed curd ready to be maturated. 
 
3.2 Cheese Ripening 
 The ripening process allows flavor, texture and aroma to develop.  For the cheddar 
cheese, an appropriate storage condition would be relative air humidity (RH) between 75% and 
80%, temperatures between 5°C and 16°C, and ripening time for 150 days (Walstra et al., 1999).  
 
Figure 3.27:  Storage of the cheddar cheese in the Dairy Store at LSU. 
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Our cheese products were stored in the cooler at 40°F (4.4°C) and RH of 85% for up to 5 months 
(Figure 3.27).  Prior to storage, the cheese was packed in labeled small plastic bags after being 
cut to small pieces to facilitate the sampling for subsequent experiments and to avoid confusion. 
3.3 Samples and Sampling 
 The cheddar cheese samples consisted of one control which was the normal sharp 
cheddar cheese and one treatment of cheddar cheese with γ-Oryzanol targeting 100mg per 
serving size (28g).  Two batches of cheeses were collected for this experiments. 
 Monthly sampling up to three months was performed during ripening in order to measure 
different aspects of the quality of the cheddar cheese.  The cheese was separated in different bags 
for different analyses (Figures 3.28 and 3.29). 
 
Figure 3.28:  Cheese separated in small bags for different analyses. 
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Figure 3.29:  Cheese packed in vacuum in small bags for different analyses. 
 
3.4 Analysis 
 Different analyses were performed for both treatment and control to determine 
differences in the quality of cheddar cheese containing γ-Oryzanol such as: color, texture, 
microbial growth, aroma development, bacterial identification by polymerase chain reaction 
(PCR), oryzanol retention, moisture content, free fatty acid profile and at the end of maturation, a 
consumer study. 
3.4.1 Color 
 The color spectrum is a combination of different parameters which are visualized in 
Figure 3.30, where L* is lightness, a* is redness and b* is yellowness. 
In a 2 dimension form, the color spectrum can be seen in Figure 3.31, where a* and b* 
were defined above and the hue angle (H°) equals tan-1 (b*/a*). 
 The L*, a* and b* parameters express the color on the basis of luminance, which is the 
descriptor of color not visible to human eyes.  a* and b* are chroma coordinates, c* is the 
derived quantities saturation (chroma) defined as a right triangle (a*2+b*2)1/2.  L* may have 
 42
values between 0 and 100, a* and b* may have values between around -80 and +80 (Berger-
Schunn, 1994) but usually are between -60 and +60.  The negative values of a* and b* show the 
greenness and blueness of the sample, respectively. 
 The vocabulary used for color analysis is the internationally accepted nomenclature of the 
CIE (Commission Internacionale de l’Eclairage; International Commission on Illumination). 
 The L*, a*, b* (CIELAB) color space and the color differences (∆E) that result from this 
color space are described with the following equation (coordinates from standardized color 
spaces and the resulting color differences are marked with an asterisk): 
∆E* = [(∆L*)2 + (∆a*)2 + (∆b*)2]1/2 
 
Figure 3.30:  3-D color spectrum. 
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 The ∆E* is the distance between two samples in a visual uniform color space 
corresponding to the color difference between the two samples. (∆ is the mathematical symbol 
for difference).  In the calculation of color difference, ∆E, with the help of all color difference 
formulas, the values of the standard always are subtracted from the values of the sample. 
 The color of the cheese was measured with a spectrophotometer Minolta model CM-508d 
Series (Osaka, Japan) with a 10° standard observer and D65 illuminant.  The following 
parameters were recorded from the machine: L*, a*, b*, c* and H°.  The spectrophotometer was 
calibrated to white with a standard supplied by the company each time a different replication was 
analyzed. 
 
Figure 3.31:  2-D color spectrum. 
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 Cheese was cut in cubes of 2cm by 2cm, allowed to cool down to room temperature and 
then color-measured by the spectrophotometer.  Twelve different cubes were analyzed for each 
replication of each sample. 
3.4.2 Texture 
 Texture profile analysis (TPA) imitates the grinding action of the jaw; it is performed by 
subjecting a specimen to a two-step compression.  The first compression step, known as the “first 
bite”, is followed by a second compression, the “second bite” (Figure 3.32).  This is to simulate 
the first two bites taken during chewing of the food (Gunasekaran and Mehmet, 2002).  The two 
compression steps may be separated by an optional wait time. 
 
Figure 3.32: Two bite compression test as performed in a typical texture profile analysis 
(www.texturetechnologies.com/texture_profile_analysis.html). 
 
A typical TPA test performed using a UTM (Universal Testing Machines) would 
generate a force-time profile as shown in Figure 3.33. 
 The many textural parameters determined from the TPA force-time (or deformation) 
curve are: hardness, cohesiveness, adhesiveness, chewiness, gumminess, springiness, and 
fracturability. 
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Figure 3.33:  Schematic of a typical two-bite texture profile analysis force-time curve 
(www.texturetechnologies.com/texture_profile_analysis.html). 
 
 Hardness (N) is the force necessary to attain a given deformation.  Fracturability (N) is 
the force at significant break in the curve on the first bite (originally known as “brittleness”).  
Cohesiveness (no units) is the strength of the internal bonds making up the body of the product 
(it can be Area 2/Area 1 or also Area 6/Area 4 from Figure 3.33).  Adhesiveness (J) is the work 
necessary to overcome the attractive forces between the surface of the food and the surface of 
other materials with which the food comes in to contact.  Gumminess (N) is the energy needed to 
disintegrate a semisolid food until it is ready for swallowing.  Chewiness (J) is the energy needed 
to chew a solid food until it is ready for swallowing.  Springiness (m) is the distance recovered 
by the sample during the time between the end of first bite and the start of second bite (originally 
known as “elasticity” – rate at which a deformed material goes back to its undeformed condition 
after the deforming force is removed).  Resilience (no units) is the measure of how well a 
product “fights to regain its original position” (Gunasekaran and Mehmet, 2002). 
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 For the TPA of the cheddar cheese, gumminess is not used since cheese is a solid and not 
a semisolid even that gumminess may be a better term than chewiness for cheese and other 
semisolid foods (Lee et al., 1978).  Also, for most cheeses and other soft foods, fracturability is 
either unidentifiable or not meaningful (Gunasekaran and Mehmet, 2002). 
 The TPA of the cheese was done with a texture analyzer Stable Micro Systems model 
TA.XT.plus (Texture Technologies Corp., New York) using a cylindrical probe TA-30 
compression platen having a diameter of 3 inches and a TA-90A flat plate with a TA-90 heavy 
duty platform.  A calibration of height and weight was performed every day the machine was 
used with the following values: height of 25mm, speed of 2 mm/sec and weight of 5 g for the 
height calibration, and a standard of 2Kg for the weight calibration. 
The TPA configuration parameters were as follows: pre-test, test and post test speed of 2 
mm/sec, compression by distance of 16mm (80% compression), a trigger system using force of 
5g, and a waiting time between cycles of 5 seconds. 
Cheese cubes of uniform 2cm by 2cm size and shape were analyzed by the texture 
analyzer to obtain the TPA.  All cubes were in the same position and direction on the platform.  
Twelve different cubes were analyzed for each replication of each sample.  After each cheese 
cube was analyzed, the probe and the base of the machine were cleaned to remove residues. 
The TA.XT.plus was equipped with the texture exponent software which provides several 
textural parameters such as: hardness, fracturability, cohesiveness, adhesiveness, gumminess, 
chewiness, springiness and resilience; all of these parameters were determined from generated 
curves, similar to the one presented in the Figure 3.33, for each of the twelvecheese cube 
analyzed. 
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3.4.3 Microbial Growth 
 The basis for the microbial plate count is to dilute the bacteria to a certain level and then 
trap them in or on a solid medium where the individual cells will divide and produce 
macroscopic colonies, which can be counted through the transparent plate and medium (Goff et 
al., 2003).  A very well known nomenclature for bacteria count is a Colony Forming Unit (CFU). 
 Decimal dilutions (10-1 to 10-8) were made from an original solution of 11g of cheese in 
99ml of PBS (phosphate-buffered saline) solution which was then put in a stomacher (Seward 
model stomacher 80, Seward, England) at high speed for 120 seconds.  The samples were 
decimally diluted and plated on to 3M™ Petrifilm™ (3M Microbiology Products, St. Paul, MN).  
The following analyses were performed: total aerobic count, E. coli and coliforms, and yeasts 
and molds.  The 3M™ Petrifilm™ for total aerobic plate count, and E. coli and coliform plates 
were incubated for 48 hours at 37°C, and yeasts and molds plates were incubated for 72 hours at 
30°C. 
By convention it is determined that a plate containing 25 to 250 colonies is ideal for 
counting.  The cheese must be sufficiently diluted to allow one plate in the dilution sequence to 
contain 25 to 250 colonies.  The bacteria were counted in a Quebec Darkfield colony counter 
(Reichert-Jung, Buffalo, NY).  And the results of these counts were presented in logarithmic 
numbers of CFU per gram that were calculated from the following equation: 
log CFU/g = log (Initial dilution x Subsequent dilution x Volume plated)-1 
3.4.4 Polymerase Chain Reaction 
 Polymerase chain reaction (PCR) is a common method of replicating specific fragments 
of DNA which rapidly amplifies a single DNA molecule into many billions of molecules.  The 
PCR can be visualized in Figure 3.34. 
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PCR is a useful tool to identify the presence of specific microorganisms due to its 
specificity to certain DNA sequences.  In this study, PCR was performed in order to determine 
the effects of γ-Oryzanol in the starter culture of cheddar cheese which was a mixture of 
Lactococcus lactis subsp. cremoris and subsp. lactis. 
Figure 3.34:  PCR (www.accessexcellence.org/AB/GG/polymerase.html) 
Bacteria of the genus Lactococcus are used world-wide for the manufacture of fermented 
dairy products.  Of particular importance are the two Lactococcus subspecies lactis and 
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cremoris.  It is necessary to differentiate L. lactis strains as either lactis or cremoris because of 
their different characteristics in cheese manufacturing.  Recently, comparison of DNA sequence 
data has shown genetic differences between the two subspecies (Ward et al., 1998). 
 The method used in the cheddar cheese containing γ-Oryzanol to identify and 
differentiate both strains relied on the PCR amplification of a 340-bp region from within the 16S 
rRNA sequence using primers Y1 and Y2 (Young et al., 1991) which anneal to highly conserved 
regions of the 16S rRNA sequence.  This amplified region contains the sequence differences 
reported between lactis and cremoris (Salama et al., 1991). 
 First, using the PCR amplification product, the ligase chain reaction (LCR) was used to 
differentiate a single base pair difference between the lactis and cremoris sequences.  Secondly, 
differences in restriction endonuclease digest patterns of the PCR amplification product were 
used to differentiate between the two subspecies. 
 The procedure to extract the bacteria from the cheese was as follows: 11g of shredded 
cheddar cheese (after 4 month-storage) in 99ml PBS (phosphate-buffered saline) in dilution 1/10 
was put in a stomacher Seward model stomacher 80 (Seward, England) at a high speed for 120 
seconds.  A part of the resulting mixture was passed through cheesecloth to filter cheese 
particles.  One ml of the solution was passed through cheesecloth then centrifuged in eppendorf 
tubes in a Eppendorf centrifuge model 5415C (Eppendorf-Netheler-Hinz GmbH, Hamburg, 
Germany) at 3000 RPM for 3 minutes.  The liquid was kept, the solid was discarded and the 
liquid part was centrifuged again at 3000 RPM for another 3 minutes.  The liquid part was kept 
and centrifuged again at 10000 RPM for 3 minutes.  The liquid part was discarded and the solid 
part was resuspended by vortexing in 0.5ml of PBS until total dissolution; this part was repeated 
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two more times.  The final pellet was resuspended in 500µl of deionized water.  Then the sample 
was heated for 5 minutes at 95°C and put in ice or frozen until performing the amplification. 
 The GeneLab PCR primers Y1 and Y2 (BioMMED, Baton Rouge, LA) used to amplify 
the 348-bp fragment from the 16S rRNA gene had the following DNA sequence: 5’-TGG CTC 
AGG ACG AAC GCT GGC GGC-3’ and 5’-CCT ACT GCT GCC TCC CGT AGG AGT-3’ 
respectively (Ward et al., 1998).  Each symbol in the sequence stands for a primary α-amino 
acid, A is alanine, C is cysteine, G is glycine and T is threonine (Fennema, 1996). 
 Before the amplification started, the primers Y1 (546µM) and Y2 (623µM) diluted at a 
ratio of 1:20 with deionized water.  Next the amplification of the samples is described.  In PCR 
tubes, 25µl of Taq PCR master mix kit (Qiagen GmbH, Hilden, Germany), 5µl of sample, 3µl of 
each primer and 14µl of water were mixed by vortexing to make a solution of 50µl. 
This solution was subjected to an amplification in a Perkin Elmer gene amplifier model 
PCR system 2400 (Perkin-Elmer, Wellesley, MA) to one cycle of 94°C for 5 minutes and 60°C 
for 4 minutes followed by 24 cycles of 94°C for 1 minute and 60°C for 2 minutes plus 72°C for 2 
minutes and kept at 4°C after the amplification was over. 
 The amplified Y1-Y2 product was digested with restriction endonucleases MboII as 
recommended by the manufacturers (New England BioLabs, Beverly, MA).  For this digestion, 
25µl of the amplified product was mixed with 1µl of MboII (5000units/ml) and 24µl of NE 
buffer 2 (10X concentrate) from New England BioLabs and incubated for 1 hour at 37°C. 
The resulting digestion products were separated in a 1% agarose gel (by electrophoresis) 
for 2.5 hours and run together with non-digested products in order to determine the presence of 
both lactis subspecies.  A 5X nucleic acid sample loading buffer (Bio-Rad Laboratories, 
Richmond, CA) was mixed in amount of 2µl with 8µl of the amplified product to be separated to 
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get a total of 10µl; each lane of the gel was loaded with 5µl of this mixture from different 
samples.  In one of the lanes, 5µl of a EZ load™ 100-bp molecular ruler of 500µg/ml (Bio-Rad 
Laboratories, Richmond, CA) was loaded. 
The 1% agarose gel was prepared by dissolving 0.24g of agarose I (Amresco, Solon, OH) 
into 30ml of 1X TBE buffer, the mixture was brought to boil while stirring, allowed to cool for 
about 5 minutes and then poured into a tray for electrophoresis.  The 1X TBE buffer is a 1:10 
dilution of a 10X TBE buffer solution prepared with 218g of Tris base, 110g of Boric acid and 
9.3g EDTA in 2L of deionized water at pH 8.3 using NaOH.  The 1X TBE buffer had to be kept 
in refrigeration, and the 10X TBE buffer was kept at room temperature.  The gel was run in a 
Pharmacia Biotech Electrophoresis Power Supply model EPS 3500 (Pharmacia Biotech, 
Sweden). 
 Immediately after the electrophoresis was completed, the DNA in the gel was stained 
with a diluted SYBR® green I nucleic acid gel stain, 10,000X concentrate in DMSO (Molecular 
probes, Eugene, OR).  This diluted stain was prepared by dissolving 30µl of the concentrated 
stain in a volume of 300ml.  The gel was immersed in the diluted stain and agitated for 15 
minutes at 40 RPM and 25°C in a Forma Scientific Orbital Shaker. 
The resulting stained gel was observed under the UV light with a Hoefer machine model 
MacroVue UVis-20 (Pharmacia Biotech Inc., San Francisco, CA) to identify bands which 
represent the presence of the lactis subspecies.  Since the cremoris PCR product is only digested 
with MBoII and the Y1-Y2 amplified fragment from lactis is not digested with MboII (Ward et 
al., 1998), it is expected to see in the gel two bands for the digested products, only one band for 
the non-digested ones; these bands in the gel will acquaint with the presence of each subspecies 
of Lactococcus lactis. 
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3.4.5 Aroma Development 
A common challenge when analyzing flavors and aromas from complex mixtures 
involves finding the best method.  Fortunately, most aroma chemicals are volatile, and 
procedures for their isolation from foods and flavors have been established.  An ideal approach 
to flavor isolation and analysis would provide an analytical sample whose composition is 
identical to the chemical mixture within the matrix, which is free of solvents and other impurities 
and could be completed within a few minutes with no intermediate processing of the samples.  
Solid-phase microextraction (SPME) approaches this ideal. 
 Figure 3.35 describes the apparatus used to extract the volatiles from cheese.  The bottom 
centimeter of the fused silica fiber is coated with a relatively thin film of any of several 
stationary phases.  This film serves as the organic “solvent” during the absorption of the volatile 
compounds from the analytical matrix.  The needle functions to puncture the septa sealing of 
both the sample container and the GC injection port and to protect the fragile fused silica fiber 
during storage and use.  A Supelco fiber of 100µm PDMS (polydimethylsiloxane) for Merlin 
Microseal™ (Supelco, Bellefonte, PA) was used for the study of aroma development in cheese. 
 In a 50ml volumetric flask, one gram of shredded cheese was placed; then 1ml of distilled 
water was added, afterwards, 0.5ml of internal standard (4-methy-2-pentanone solution of 
0.005µl/ml of hexane) was added.  The mixture was thoroughly mixed for a few seconds 
(equilibration rate increases), sealed with the septum type cap and the fiber inserted through the 
septa.  Immediately afterward, the flask was put in the water bath at 65°C for 20 minutes. 
 The SPME process is illustrated in Figure 3.36 which is similar to the one we used in the 
analysis of cheese.  During headspace sampling the PDMS fiber is extended into the vapor phase 
above the sample.  After 20 minutes, the fiber was taken out of the flask and injected into the 
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GC-MS Varian model Saturn 2200 with a gas chromatograph Varian model CP-3800 (Varian 
Chromatography Systems, Walnut Creek, CA) with FID (flame ionization detector) for 
separation and analysis of the volatiles. 
 
Figure 3.35:  Graphic representation of a solid-phase microextraction (SPME) device (Zhang et 
al., 1994). 
 
The mobile phase of the system was helium at a flow rate of 0.8ml/min.  The oven 
temperature started at 30°C and held for 2.5 minutes, then it was increased to 45°C at a rate of 
2°C/min; as soon as the temperature reached 45°C, the increase rate was of 5°C per minute until 
the oven temperature reached 180°C.  Then the temperature was increased to 200°C at a rate of 
 54
20°C per minute, and this temperature was held for 2 minutes to make a total analysis time of 40 
minutes.   
 
Figure 3.36:  Sequence of events showing extraction steps and desorption (injection) steps 
followed to perform an analysis using SPME.  The fiber is inserted directly into a liquid sample 
with the subsequent absorption of most of the analyte molecules (small circles) from the solution 
(Marsili, 1997). 
 
The chromatograms obtained from the GC-MS helped to determine the most important 
aroma and flavor peaks in the samples and their changes during ripening, which were measured 
by their height (kilocounts) since the software available could not quantify the peaks. 
3.4.6 Oryzanol Retention 
 Since γ-Oryzanol is fat soluble, the first part of the analysis was to extract the lipid 
fraction of the cheese.  5ml of a Chloroform-Methanol 2:1 solution (solvent) was added to a flask 
containing 1g of shredded cheese and then mixed in a vortex for several seconds (until total 
destruction of cheese texture).  This mixture was heated and agitated constantly in a water bath at 
40°C for 10 minutes, then mixed in a vortex again for a few seconds.  The blend was then 
centrifuged at 2500 RPM and 20°C for 5 minutes.   
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The liquid part was put in another flask in a rotary evaporator under vacuum at 60°C to 
obtain crude oil (Xu et al., 1999).  The solid part was treated as follows: 5ml of hexane (solvent) 
was added and then mixed in a vortex for several seconds the new blend was centrifuged again at 
2500 RPM and 20°C for 5 minutes, and the liquid part was separated from the solid. This whole 
process was repeated two more times. 
Once the three extractions with hexane were done, the solid part was discarded, and after 
all the solvent was evaporated, the samples were prepared to be analyzed by HPLC.  The 
extracted liquid which contained all the lipids (crude oil) from the cheese was dissolved in 5ml 
of hexane and put in vials for analysis. 
The dissolved samples were injected into the HPLC system consisting of a Waters™ 486 
tunable absorbance detector, a Waters™ 717plus autosampler and a Waters™ 470 scanning 
fluorescence detector for separation and analysis of γ-Oryzanol in the lipid extraction.  The 
chromatograms obtained from the HPLC were used to determine the concentration of γ-Oryzanol 
retained in the cheese.  The software calculated the area under the oryzanol peaks and its 
concentration was calculated using the following parameters: 
The calibration curve between area under the peak and oryzanol content is: 
Peak area = 123368 x oryzanol content (µg) 
Injection volume: 25µl of extracted lipid sample 
Dilution factor: 5ml of hexane 
Serving size of cheddar cheese: 28g 
With these parameters mentioned above and making conversions between µg and mg, and µl and 
ml, the following equations were used to determine the concentration of oryzanol in a serving 
size of cheddar cheese (mg/serving size): 
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3.4.7 Moisture Content 
 The moisture content was determined by means of a microwave oven which uses 
microwave energy to heat samples to remove moisture.  Factors affecting the drying are time, 
sample size, placement of sample in oven, and energy of microwaves (Richardson, 1985). 
 The microwave oven used for this analysis was a CEM model Smart System 5 (CEM 
Corp., Matthews, NC) with the following parameters set: weight range of 2-4 grams, a power of 
100%, delta weight of 0.5mg, delta time of 10 seconds, maximum time of 4 minutes, maximum 
temperature of 130°C and no weight compensation. 
 Shredded cheese (2 to 3 grams) was put between CEM square sample pads specific for 
this machine (part # 200150, CEM Corp., Matthews, NC) and then analyzed. 
3.4.8 Free Fatty Acid Profile 
The method used to analyze the free fatty acid profile of the cheese was similar to the one 
used for the determination of the oryzanol retention (section 3.4.6), however, with slight 
changes. 
The first part of the analysis was to extract the lipid fraction of the cheese.  5ml of a 
Chloroform-Methanol 2:1 solution (solvent) was added to a flask containing 1g of shredded 
cheese and 1ml of a solution of internal standard consisting of 0.4652g of heptadecanoic acid 
(C17:0) in 50ml of hexane (C6H14).  The mixture was mixed in a vortex for several seconds until 
total destruction of cheese texture.  This mixture was heated and agitated constantly in a water 
bath at 40°C for 10 minutes, and then mixed in a vortex again for a few seconds.  The blend was 
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then centrifuged at 2500 RPM and 20°C for 5 minutes in a Hermle Labnet centrifuge model 
Z383K (Hermle Labortechnik, Wehingen, Germany).   
The liquid part was poured in another flask in a Labconco rotary evaporator model 
CentriVap Console under vacuum at 60°C to obtain crude oil (Xu et al., 1999).  The solid part 
was treated as follows: 5ml of hexane (solvent) was added and then mixed in a vortex for several 
seconds; the new blend was centrifuged again at 2500 RPM and 20°C for 5 minutes, and the 
liquid phase was separated from the solid.  The evaporation process was performed two more 
times. 
Once the three extractions with hexane were done, the solid part was discarded, and after 
all the solvent was evaporated, the samples were prepared to be analyzed by GC.  The extracted 
liquid which contained all the lipids (crude oil) from the cheese was dissolved in 6ml of hexane 
together with 2ml of a solution of Boron trichloride (BCl3) and methanol (Supelco, Bellefonte, 
PA) and 1ml of 2,2-dimethoxypropane (Sigma-Aldrich Co., St. Louis, MO).  After agitating in 
vortex for a few seconds, the upper layer (hexane) was transferred to a test tube where a few 
crystals of sodium sulfate anhydrous (NaSO4) were added to absorb moisture, and then the 
hexane extract was transferred to GC sample vials ready for analysis. 
The hexane extract samples were injected into the gas chromatograph Hewlett Packard 
model 5890A (HP, San Fernando, CA) for separation and analysis of free fatty acids between C4 
and C18 in the lipid extraction.  The mobile phase of the system was Helium.  The 
chromatograms obtained from the GC were used to help determining the concentration of the 
different fatty acids present in the cheese.  The software calculated the areas under the peaks and 
their concentrations were calculated using the following parameters: 
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The relationship between peak areas and concentrations (conc.) of a free fatty acid (FFA) and 
internal standard (I.S.) is: 
.conc.S.I
.concFFA
.S.IArea
FFAArea =  
Injection volume: 3µl of extracted lipid sample 
Dilution factor: 6ml of hexane 
I.S. concentration: 0.4652g/50ml hexane 
I.S. solution volume: 1ml 
With these parameters mentioned above and making conversions between µg and mg, grams and 
Kg, and µl and ml, the following equations were used to determine the concentration of each free 
fatty acid in the cheese (mg/Kg of cheese): 
)g(weightSampleml/l1000ml6ml50
Kg/g1000g/mg1000l3ml1g4652.0)Kg/mg.(conc.S.I ×µ××
××µ××=  
.S.IArea
FFAArea)Kg/mg.(conc.S.I)Kg/mg.(concFFA ×=  
 The results for the free fatty acid profile were expressed in percentage based on the total 
amount of each FFA from C4 to C18, and the total amount of all FFA together. 
3.5 Consumer Study 
 With the aim of understanding prospective buyers of a specific product and how this 
product can be introduced into the market, the use of sensory affective tests can assist food 
scientists and developers to understand the behavior of different consumers groups (Piggot, 
1988).  This type of affective test is a very accurate tool in recognizing consumer preferences. 
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 Quantitative affective tests determine responses of a large group of consumers to a set of 
questions regarding preference, liking, sensory attributes, etc. (Meilgaard et al., 1999).  They 
obtain more data and information in less time than do qualitative tests. 
 The hedonic scale is a common tool to quantify consumer acceptance.  The 9-point 
hedonic scale is a rating scale that has been used for many years in sensory evaluation in the food 
industry to determine the acceptance of a food and to provide a bench mark for comparison.  Its 
use has been validated in the scientific literature (Stone et al., 1993).  The number of scale 
categories that have been used include the 5-, 7- and 9-point scale.  The 3-point scale is not 
recommended for use with adult consumers, because adults tend to avoid using the extreme 
points of the scale in rating food product samples (Resurreccion, 1998). 
 Overall appearance includes all visible sensory attributes such as color, size, shape and 
surface texture.  Appearance is commonly used by consumers to infer food product quality; 
frequently this is the only cue available, especially at the moment of purchase (Schröder, 2003).  
Flavor involves attributes like taste, specific flavors, aroma, etc.  Aroma is the odor of a food 
resulting from the process that involves the passing of volatiles through the nasal passages 
located in the nose when a person inhales them (Meilgaard et al., 1999).  Overall liking can be 
defined as a complex expression of liking of the product as a whole (Pavon, 2003). 
 In order to find if consumers can detect overall difference and/or difference in a specific 
attribute(s) between two or more samples, discriminative sensory testing can be utilized.  The 
applications of these tests are to determine if products differ due to changes in ingredients, 
processing, storage, etc., if an overall difference exists where no specific attribute(s) can be 
identified as having been affected, if a specific attribute(s) of the products differ or if the 
consumer is able to discriminate between test samples. 
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 The traditional R-Index method and the bipolar and/or weighted R-Index method are 
discriminatory sensory tests from which the researcher can determine if panelists can detect 
differences in specific attributes between samples.  Both methods present a signal (S) sample that 
is the new, reformulated, or improved product and the noise (N) sample which is the current, 
existing, or control product.  The panelists’ task is to indicate if he/she is sure or not sure that 
samples are different or the same.  They can also indicate if the samples are more or less intense 
in specific attributes.  The R-Index is a probability value of a given judge distinguishing 
correctly between 2 samples. 
Research was conducted including four parts, a consent form (see Appendix B), a 
demographic and socioeconomic survey, an affective test, and the R-index with the traditional 
method and the bipolar method (see Appendix C).  The consent form included some general 
explanation of the questionnaire to be filled by the panelist, stating the presence of potential 
allergens, contact information in case of interest in further knowledge about the topic and the 
purpose of the study; the demographic and socioeconomic survey asking age, gender, race, level 
of education and household income; the affective test included the rating of the overall 
appearance, smoothness of color (yellowness), odor/aroma, taste, overall texture/mouthfeel and 
overall liking with a 9-point hedonic scale (1=dislike extremely, 5=neither like nor dislike, and 
9=like extremely) (Peryam et al., 1957).  The affective test asked consumers to evaluate the 
detection of a bitter aftertaste, the acceptance and the interest in buying a cheddar cheese 
containing γ-Oryzanol, an antioxidant and potential cholesterol reducing compound from rice 
bran using a yes/no scale (Moskowitz, 1994).  The R-Index included the overall appearance, 
overall color and yellowness for the visual evaluation, odor for the aroma evaluation, taste, 
overall texture, hardness and chewiness for the gustatory evaluation.  The yellowness, hardness 
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and chewiness were evaluated as a bipolar R-index, the rest were treated as the traditional R-
Index. 
Untrained consumers (n=100) were randomly recruited from Louisiana State University 
(LSU) campus and vicinities in Baton Rouge.  The recruitment consisted of flyers, phone calls, 
emails and posting advertisements on LSU campus.  Requirements to be a panelist were: (1) to 
be at least 18 years old, (2) not having allergic reactions to cheese and rice products and (3) 
positive attitude with disposition of time to complete a questionnaire.  The consumer session was 
carried out on May 29th, 2004, between 10 a.m. and 4 p.m. in the dairy store of the Dairy Science 
department in LSU. 
Consumers were instructed on the procedure to be followed.  They were informed that 
each sample was randomly coded with a 3-digit number, 705 for control and 485 for treatment.   
They were familiarized with the (S) signal and (N) noise samples, and asked whether they were 
sure or not sure that samples were different or the same.   They were also asked whether they 
were sure or not sure that samples were more or less intense in specific attributes. 
The sample preparation consisted of trimming the outer portion of the block cheese 
(Figure 3.37).  Samples were not allowed to dry out by wrapping them with plastic to prevent 
loss of moisture, and they were kept refrigerated.  Samples were cut to 2cm cubes with a cheese 
wire (Figure 3.38).  Although cheese should be stored in the refrigerator, cheese was removed to 
allow enough time to equilibrate twenty to thirty minutes before being served to the consumers at 
ambient temperature (Resurreccion, 1998). 
The samples were served to the seated panelists on a tray with a cup of drinking water at 
room temperature, unsalted crackers, toothstick and a napkin as shown in Figure 3.39, in a room 
with controlled light, positive airflow and free of distracting odors, together with an explanation 
 62
of the procedure to follow and the questionnaire including the four parts mentioned above in this 
section. 
 
Figure 3.37:  Trimming outer part of block cheese. 
 
 
Figure 3.38:  Cutting cheese samples to 2cm-cubes with a cheese wire. 
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Figure 3.39:  Sample presentation for consumer study. 
 
3.6 Statistical Analysis 
3.6.1 Physicochemical and Biological Analysis 
 The statistical analysis of color, texture, microbial growth, aroma development, oryzanol 
retention, moisture content and free fatty acid profile was performed using the software SAS 
version 9.00, 2002 (SAS Institute Inc., Cary, NC) (SAS codes are in Appendix D).   
The GLM or ANOVA test was used to test the null hypothesis H0: µcontrol = µtreatment with 
an alternative hypothesis H1: µcontrol ≠ µtreatment, and Tukey’s honestly significant difference 
(HSD) test with the studentized range was applied to determine significant differences in each 
sample (control and treatment analyzed separately) within different ripening times.  The 
significance level (α) for this test was set at 0.05.  
A two-sample t-test was used for the null hypothesis H0: µcontrol - µtreatment = 0 and an 
alternative hypothesis H1: µcontrol - µtreatment ≠ 0 to determine if there were significant differences 
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between samples (control and treatment).  This test, by the F test of variances with a significance 
level (α) of 0.2, judged if two estimates of variance from different populations could be 
combined; pooling variances together turns into a single more powerful variance and the 
following assumptions are taken: the differences are normally distributed, the observations and 
samples are independent and the variance is homogenous (Freund et al., 1997).  Whether the 
variances can be pooled together or not, SAS gives probabilities for equal and unequal variances.  
The second part of the two-sample t-test uses a significance level (α) of 0.05 for the t-test which 
determine significant differences found between samples using the hypotheses mentioned at the 
beginning of this paragraph. 
3.6.2 Sensory Evaluation 
3.6.2.1 R-Index 
To determine if an overall difference exists in the cheese containing γ-Oryzanol and 
whether the cheese differs due to the presence of γ-Oryzanol, the discriminative sensory test, i.e., 
R-Index was used (traditional and bipolar tests).  The traditional R-Index indicates the degree of 
difference between the S (signal) and N (noise) samples; a higher R-Index value indicates better 
discrimination. 
 For the traditional R-Index, the data obtained from the questionnaire were: consumer was 
certain that the sample was the treatment (S), that perhaps the sample was the treatment but not 
sure (S?), that perhaps the sample was the control but not sure (N?) or that definitely the sample 
was the control (N).  With this data tabulated, the Table 3.1 was built. 
From data tabulated as shown in Table 3.1, the traditional R-Index in percentage could be 
calculated with the following equation: 
[ ] ( )[ ]
( ) ( ) 100hgfedcba
dhcgbfae5.0ch)hg(b)hgf(aIndexR ×+++×+++
+++×+++×+++×=−  
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Table 3.1:  Tabulated information needed to calculate the traditional R-Index. 
Consumer’s responses Sample 
(code) S                         S?                      N?                     N 
Total 
S (485) a b c d ns=a+b+c+d 
N (705) e f g h nN=e+f+g+h 
S (485) = cheese containing γ-Oryzanol; N (705) = cheese without γ-Oryzanol; S= different sure; 
S?= different unsure; N?= same unsure; N= same sure. 
 
 The Table with critical values of R-Index expressed in % of R-Index-50% (Bi et al., 
1995) was used to determine the critical R-Index value by using the number of signal or noise 
samples (N) to obtain the R-Index in the equation above and the significance level (α) for a 1-
tailed or 2-tailed test.  If the researcher knows that the signal can only be stronger or weaker than 
the noise then the test is 1-tailed, otherwise it is a 2-tailed test.  For the traditional R-Index, the 
calculations were made based on a 2-tailed test since assumptions were not made about 
differences between samples.  The null hypothesis (H0: the %R-Index is equal to a chance 
(50%)) tells whether the consumer detected a difference in the samples by guessing or by chance.   
If the R-Index value obtained from the equation above was equal to or greater than the 
critical value, then the consumer noticed a difference between samples not by chance.  If this 
value was smaller than the critical value, then the consumer either noticed a difference between 
samples most probably by chance or could not differentiate the samples. 
 For the bipolar R-Index, the data obtained from the questionnaire was: in one part, that 
the consumer was certain the sample had more intensity of the attribute than the control (S+), 
that perhaps the sample had more intensity of the attribute than the control (S+?), that perhaps 
the sample had the same intensity of the attribute than the control but not sure (N?) or that 
definitely the sample had the same intensity than the control (N); in the other part, that the 
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consumer was certain the sample had less intensity of the attribute than the control (S-), that 
perhaps the sample had less intensity of the attribute than the control (S-?), that perhaps the 
sample had the same intensity of the attribute than the control but not sure (N?) or that definitely 
the sample had the same intensity than the control (N).  With this data tabulated, tables like 
Table 3.2 and 3.3 could be built. 
From data tabulated as shown in the Tables 3.2 and 3.3, the bipolar R-Indices (Rmore and 
Rless) could be calculated with the same equation used for the traditional R-Index.  The critical R-
Index value for the bipolar method was calculated the same way as the traditional R-Index was 
done with the only change that it was a 1-tailed test. 
Table 3.2:  Tabulated information needed to calculate the bipolar R-Index (Rmore). 
Consumer’s responses Sample 
(code) S+                       S+?                    N?                     N 
Total 
S (485) a b c d ns=a+b+c+d 
N (705) e f g h nN=e+f+g+h 
S (485) = cheese containing γ-Oryzanol; N (705) = cheese without γ-Oryzanol; S+= more sure; 
S+?= more unsure; N?= same unsure; N= same sure. 
 
Table 3.3:  Tabulated information needed to calculate the bipolar R-Index (Rless). 
Consumer’s responses Sample 
(code) S-                       S-?                     N?                     N 
Total 
S (485) a b c d ns=a+b+c+d 
N (705) e f g h nN=e+f+g+h 
S (485) = cheese containing γ-Oryzanol; N (705) = cheese without γ-Oryzanol; S-= less sure;  
S-?= less unsure; N?= same unsure; N= same sure. 
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 The decision of taking Rmore or Rless as the real R-Index value was based on the frequency 
of repetition of S+ and S+?, and S- and S-?.  The ones with the highest proportion would be the 
R-Index value taken.  If there was not a big difference in the frequency of repetition of S+ and 
S+?, and S- and S-?, either R-Indices values could be taken, or the calculations could be done as 
a traditional R-Index method, like mentioned above. 
3.6.2.2 The McNemar Test 
 With the intention of analyzing the change in probability of purchase intent before and 
after consumers had been informed about the potential health benefits of the cheese, the 
McNemar test was performed using proc freq/agree of software SAS version 9.00, 2002 (SAS 
Institute Inc., Cary, NC) (code is in Appendix D).   
The McNemar test represents a comparison of dependent proportions for binary response 
variables, and it is a two-related sample difference test that follows a Chi-square (χ2) distribution 
with a degree  of freedom (df) of one (Agresti, 1996).  Consumers are categorized in two 
categories: before they have been informed about health benefits of cheese containing γ-
Oryzanol and after they have been informed about the health benefits (O’Mahony, 1986). 
 The null hypothesis (H0: π+1 = π1+) states that there is no significant difference in the 
probability of buying the cheese before and after consumers had been informed about its health 
benefits (π+1 is the probability of those who answered yes after, and π1+ is the probability of 
those who answered yes before).  The aim of this test is to know if participants were influenced 
or not by the health benefits of this product and, therefore, to determine if their opinions changed 
from a “before” status to an “after” status. 
To complement McNemar test and obtain more detailed understanding about changes in 
consumer purchase decision, a 95% confidence interval for the difference of proportions was 
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calculated.  The difference of two sample marginal proportions (p+1 - p1+) estimates the true 
difference (π+1 - π1+ or π21 – π12).  The sample proportions were calculated using the next 
equation: 
pij = nij/N 
where nij is the number of subjects making response i at the first question (before), and response j 
at the second question (after knowing that the product contained health promoting ingredients), 
and N is the total number of responses.  The confidence interval of difference of proportions is 
calculated as follows: 
(p+1 - p1+)±zα/2(ASE) 
where (p+1 - p1+) indicates the difference between the proportion of participants that answered 
“yes” after knowing that the cheese contained health promoting compounds p+1, and the 
proportion of participants that answered “yes” before knowing that the product contained health 
promoting ingredients (p1+); the zα/2 denotes the standard normal percentile having a right-tail 
probability equal to α/2; ASE is the estimated standard error for the proportion difference. 
ASE is calculated with the following equation: 
N
)pppp(2)p1(p)p1(pASE 211222111111 ×−××−−×+−×= ++++  
where p11 is the proportion of subjects that answered “yes” before knowing and “yes” after 
knowing, p22 is the proportion of subjects that answered “no” before knowing and “no” after 
knowing, p12 is the proportion of subjects that answered “yes” before knowing and “no” after 
knowing, and p21 is the proportion of subjects that answered “no” before knowing and “yes” after 
knowing.  When 0 is included in the confidence interval, then there is no significant difference. 
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3.6.2.3 Consumer Acceptance Test 
 Univariate and multivariate statistical analyses were performed to determine consumers’ 
perceptions and preferences in the acceptability of each different sensory attribute as well as in 
overall liking of the cheese samples by using the software SAS version 9.00, 2002 (SAS Institute 
Inc., Cary, NC) (codes are in Appendix D). 
An analysis of variance (ANOVA) was used to determine differences in acceptability for 
each of the sensory attributes among the samples, and Tukey’s honestly significant difference 
(HSD) test with studentized range, which can be applied regardless of whether the overall test for 
differences is significant among the samples (Meilgaard et al., 1999), was applied to determine if 
the samples were significantly different.  The significance level (α) for this test was set at 0.05. 
A multivariate analysis of variance (MANOVA) was performed as an extension of the 
ANOVA test.  However, more than one variable is tested to detect differences in groups across 
multiple dependent variables at the same time (Pavon, 2003).  MANOVA can determine overall 
differences in the acceptability among the samples, including all sensory attributes 
simultaneously. 
Descriptive discriminant analysis (DDA) was done to identify any discriminating sensory 
acceptability attributes that may have contributed to differences among samples and to the 
cheese in general. 
Logistic regression models are useful to describe the effect of predictors (independent 
variables) on a binary dichotomous response variable (dependent variable), which follows an S-
shaped curve (Agresti, 1996).  Logistic regression was used to predict acceptance by using what 
is known as the odds ratio estimate.   
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When an estimated odds ratio equals 1.0, it means that there is no significant association 
between the two variables (Agresti, 1996).  To be precise, the probability of success remains 
constant through the change of the independent variables.  The higher the odds ratio estimate is, 
the more contribution from that specific attribute exists to the acceptability of the sample.   
For the detection of a bitterness aftertaste, the acceptability of the cheese, and the interest 
in buying the cheddar cheese containing γ-Oryzanol before and after knowing the potential 
health benefits of it, a simple frequency analysis was performed. 
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CHAPTER 4. RESULTS AND DISCUSSION 
4.1 Color 
The analysis of variance and a post-hoc test indicated an existence of significant 
differences (p<0.0001) in all color parameters in cheese during ripening process.  Pairwise tests 
between some months based on whiteness (L*), redness (a*), yellowness (b*) and huge angle 
(H°) measurements showed significant differences (p<0.05) for both control and treatment 
samples (Tables 4.1 and 4.2).  L* and a* decreased for both control and treatment samples 
during time, and b* and H° increased in both samples, which means that there was less red and 
white and more yellow in the sample during ripening.  The significant differences were noticed 
after one and two months of maturation for both samples but the treatment also showed 
differences in the month 4. 
Table 4.1:  Means and standard deviations of L* (lightness), a* (redness), b* (yellowness) and 
H° (hue angle) of control samples without γ-Oryzanol at different stages of maturation. 
 
Parameter 
Month 
L*                           a*                            b*                           H° 
0 78.11 (1.37)a 10.46 (1.27)a 34.56 (1.64)c 73.22 (1.26)b 
1 75.74 (1.27)b 11.22 (1.02)a 37.15 (2.21)b 73.22 (0.92)b 
2 75.65 (1.79)b 7.79 (0.98)b 39.45 (2.30)a 78.80 (1.12)a 
3 75.78 (1.63)b 7.81 (1.16)b 39.29 (2.07)a 78.79 (1.28)a 
4 74.83 (1.38)b 8.09 (1.05)b 40.93 (3.16)a 78.83 (1.06)a 
a,b,c Means within same column followed by different superscripts are significantly different 
(P<0.05). 
 
When comparing color parameters between samples (control and treatment) at different 
stages of maturation, the significant differences were observed (Table 4.3).  L* and b* showed 
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less significant differences between samples than a* and H°, and the former two parameters had 
significant differences up to the third month of maturation, L* had them between the first and 
third month and b* just in the first and third month. 
Table 4.2:  Means and standard deviations of L* (lightness), a* (redness), b* (yellowness) and 
H° (hue angle) of treatment samples with γ-Oryzanol at different stages of maturation. 
 
Parameter 
Month 
L*                           a*                            b*                           H° 
0 77.46 (1.54)ab 9.60 (1.06)b 34.30 (1.82)c 74.40 (1.21)c 
1 76.96 (0.80)ab 10.35 (0.61)a 35.65 (1.61)bc 73.81 (0.60)c 
2 76.63 (0.89)b 6.93 (0.72)d 39.23 (2.75)a 79.99 (0.51)a 
3 77.85 (0.59)a 6.53 (0.50)d 36.93 (2.02)b 79.97 (0.64)a 
4 75.58 (2.07)c 7.65 (1.15)c 39.46 (3.29)a 79.04 (1.32)b 
a,b,c,d Means within same column followed by different superscripts are significantly different 
(P<0.05). 
 
Table 4.3:  Probabilities of significant differences (Pr>|t|) in L* (lightness), a* (redness), b* 
(yellowness) and H° (hue angle) between control (without γ-Oryzanol) and treatment (with γ-
Oryzanol) samples during ripening. 
 
Parameter 
Month 
L*                           a*                            b*                            H° 
0 0.1279 0.0142* 0.6153 0.0019* 
1 0.0003* 0.001* 0.0103* 0.0112* 
2 0.0235* 0.0014* 0.7608 <0.0001* 
3 <0.0001* <0.0001* 0.0002* 0.0003* 
4 0.1456 0.1719 0.1210 0.5444 
*Probabilities smaller than 0.05 (α) indicate significant differences between samples. 
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Total color difference was calculated in two different ways: comparing control and 
treatment samples at different stages of ripening (Figure 4.1), and comparing each sample at 
different months with the control sample at month 0 (Figure 4.2).  From these figures, it can be 
seen that there is a slight increase in color difference (∆E*) during the ripening of the cheese. 
It cannot be said that there is a clear tendency of the color difference to increase during 
maturation of cheese when comparing the ∆E* in Figure 4.1, just that there is a difference in 
color between control and treatment samples at different stages of maturation. 
Figure 4.1:  Total color difference (∆E*) between control (without γ-Oryzanol) and treatment 
(with γ-Oryzanol) samples at different stages of cheese ripening. 
 
 It can be concluded that the difference in color for months 1, 2, 3 and 4 is higher than 
month 0.  This means that the difference between control and treatment is larger. 
 In Figure 4.2, it can be noted that during the ripening process, the color difference of each 
sample at each stage of ripening compared with the control sample at month 0 tends to be 
smaller for the treatment samples than for the control. 
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 From the obtained results of color parameters (L*, a*, b* and H°) and total color 
difference (∆E*), and the subsequent statistical analysis, it can be concluded that γ-Oryzanol was 
not an important factor affecting the color difference of cheddar cheese.  Also time was a 
significant factor affecting the color changes in cheese since both comparisons (Figure 4.1 and 
4.2) showed an increase of color differences during time. 
Figure 4.2:  Total color difference (∆E*) comparing samples with γ-Oryzanol and without γ-
Oryzanol at all times with the control sample (without γ-Oryzanol) at month 0. 
 
4.2 Texture 
The results of textural parameters obtained from the texture exponent software for both 
control and treatment samples are presented in Tables 4.4 and 4.5, respectively.   These tables 
also show the significant differences when comparing each sample within different months of 
ripening.  The analysis of variance and a post-hoc test indicated an existence of significant 
differences (p<0.0001) in all textural parameters evaluated in cheese during the ripening process.  
Pairwise tests between some months within the same sample based on hardness, cohesiveness, 
adhesiveness, gumminess, chewiness, springiness and resilience results were significantly 
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different (p<0.05) for both control and treatment samples.  The most important changes were in 
the hardness and gumminess which decreased during time over the four months of the study for 
both control and treatment samples.  The other parameters also decreased during time but in a 
smaller ratio. 
Springiness and resilience showed to have more differences between months for both 
control and treatment than the other textural parameters evaluated.  Cohesiveness showed more 
significant differences in treatment samples; hardness had less significant differences than the 
other parameters in question for both samples, and chewiness and gumminess showed the same 
degree of difference between months for both samples, being between springiness and resilience, 
and hardness. 
Table 4.4:  Means and standard deviations of textural parameters of control samples without γ-
Oryzanol at different stages of maturation. 
 
Parameter 
 Month 
Hardness  Cohesiveness  Gumminess   Chewiness     Springiness   Resilience 
(N)                 (-)                  (N)                 (J)                  (m)                 (-) 
0 215.33 
(34.68)a 
0.27  
(0.03)a 
58.25 
(12.31)a 
0.78  
(0.18)a 
0.01  
(0.00)a 
0.13  
(0.01)a 
1 157.18 
(72.42)b 
0.22  
(0.03)b 
36.52 
(23.02)b 
0.44  
(0.26)b 
0.01  
(0.00)b 
0.11  
(0.02)b 
2 165.73 
(57.13)b 
0.20 
(0.02)bc 
34.23 
(13.72)bc 
0.32 
(0.12)bc 
0.01  
(0.00)c 
0.09  
(0.01)c 
3 129.72 
(32.25)b 
0.19  
(0.03)c 
24.97 
(7.23)c 
0.22  
(0.05)c 
0.01  
(0.00)c 
0.08  
(0.01)d 
4 145.94 
(30.49)b 
0.21 
(0.02)bc 
30.63 
(8.42)bc 
0.25  
(0.06)c 
0.01  
(0.00)d 
0.08 
(0.01)cd 
a,b,c,d Means within same column followed by different superscripts are significantly different 
(P<0.05). 
 
The adhesiveness is not included in the Tables 4.4 and 4.5 because both samples, control 
and treatment, gave an adhesiveness of 0 Joules at all times.  The fracturability is also not 
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included in the results because it was present in just few samples and replications, and it was not 
representative of the behavior of textural changes. 
Table 4.5:  Means and standard deviations of textural parameters of treatment samples with γ-
Oryzanol at different stages of maturation. 
 
Parameter 
 Month 
Hardness  Cohesiveness  Gumminess   Chewiness     Springiness   Resilience 
(N)                 (-)                  (N)                 (J)                  (m)                 (-) 
0 170.73 
(53.37)a 
0.26  
(0.04)a 
45.39 
(21.01)a 
0.58  
(0.26)a 
0.01  
(0.00)a 
0.13  
(0.02)a 
1 146.87 
(43.66)ab 
0.22 
(0.03)bc 
32.28 
(13.48)bc 
0.37  
(0.16)b 
0.01  
(0.00)b 
0.11  
(0.01)b 
2 179.85 
(50.32)a 
0.20  
(0.03)c 
36.52 
(14.83)ab 
0.33  
(0.14)b 
0.01  
(0.00)c 
0.10  
(0.02)c 
3 121.93 
(27.20)b 
0.17  
(0.02)d 
21.30 
(6.22)c 
0.19  
(0.06)c 
0.01 
(0.00)cd 
0.08  
(0.01)d 
4 161.44 
(46.23)a 
0.22  
(0.03)b 
36.36 
(11.94)ab 
0.28 
(0.07)bc 
0.01  
(0.00)d 
0.09  
(0.01)c 
a,b,c,d Means within same column followed by different superscripts are significantly different 
(P<0.05). 
 
When comparing the results of hardness, cohesiveness, gumminess, chewiness, 
springiness and resilience between samples (control and treatment) at different stages of 
maturation, the differences seemed to be not very significant, as shown in Table 4.6.  Just few 
pair-wise comparisons between control and treatment at a specific stage of the maturation give 
the impression to be significantly different, and the rest does not show any significant difference 
at all.  Cohesiveness showed more differences at the third and fourth month, hardness, 
gumminess and chewiness at month 0, and resilience at the last month of analysis; springiness 
showed significant changes in the first month, and chewiness also showed changes in month 3. 
 Hardness, cohesiveness, gumminess, chewiness, springiness and resilience showed 
significant differences when compared between months within the same sample; they barely 
showed significant differences when compared between samples of the same maturation time.  
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Adhesiveness showed to be the only textural parameter which did not show a significant 
difference at all, 0 Joules for all times, samples and replications. 
Table 4.6:  Probabilities of significant differences (Pr>|t|) in texture parameters between control 
(without γ-Oryzanol) and treatment (with γ-Oryzanol) samples during ripening. 
 
Parameter 
 Month 
Hardness  Cohesiveness  Gumminess   Chewiness     Springiness   Resilience 
0   0.0014* 0.1953   0.0137*   0.0043* 0.2044 0.4699 
1 0.5540 0.5180 0.4418 0.2397   0.0123* 0.2700 
2 0.3726 0.3945 0.5866 0.8895 0.3572 0.2465 
3 0.3714   0.0078* 0.0685   0.0272* 0.4994 0.1628 
4 0.1779   0.0216* 0.0614 0.1020 0.2979   0.0125* 
*Probabilities smaller than 0.05 (α) indicate significant differences between samples. 
Texture profile analysis showed some differences during ripening within the same 
samples but it did not show any major differences between control and treatment cheese samples 
during this time; all of which leads to the conclusion that γ-Oryzanol did not change textural 
conformation of cheddar cheese significantly.   
All textural parameters evaluated, with exception of springiness, tended to decrease 
during time until the third month, and the fourth month showed a slight increase.  For springiness 
there was not any increase in the fourth month, including both control and treatment samples (see 
Figures 4.5 to 4.10 in Appendix A for graphical trend of data in Tables 4.4 and 4.5). 
4.3 Microbial Growth 
The pattern of aerobic bacteria and coliform growth in both control and treatment 
samples during maturation is presented in Table 4.7.  In this table, it can be seen the significant 
differences existing when comparing each sample within different months of ripening. 
The analysis of variance and a post-hoc test indicated an existence of significant 
differences (p<0.0208 for aerobic bacteria and p<0.0001 for coliforms) in microbial growth in 
cheese during the ripening process.  Pairwise comparisons between some months based on 
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aerobic plate count and coliform count were significantly different (p<0.05) for both control and 
treatment samples.   
Table 4.7:  Means and standard deviations of microbial growth of control (without γ-Oryzanol) 
and treatment (with γ-Oryzanol) samples at different stages of maturation. 
 
Microbial count 
Aerobic Plate (log CFU/g)                     Coliform Plate (log CFU/g) Month 
Control                  Treatment              Control                  Treatment 
0 6.74 (0.36)a 6.71 (0.23)a 4.36 (0.31)a 4.53 (0.07)a 
1 6.44 (0.26)ab 6.68 (0.06)a 2.83 (0.18)b 1.48 (2.09))ab 
2 5.29 (0.12)ab 5.66 (0.08)b 2.50 (0.28)b 2.39 (0.55)ab 
3 5.32 (0.72)ab 5.34 (0.37)b ND ND 
4 5.02 (0.04)b 5.19 (0.07)b ND ND 
a,b,c Means within same column followed by different superscripts are significantly different 
(P<0.05). 
ND = not detectable; detection limit: 10 CFU/g. 
 
The decline in both coliforms and aerobic bacteria for both samples over time could have 
been due to the acid production of the lactic acid bacteria used in the starter culture which slowly 
decreased the aerobic bacteria and coliform counts over time. 
Yeasts and molds were not present in any of the samples at different stages of maturation 
with the method and conditions used in the experiment.  E. coli was not present in any of the 
samples either; Reddy et al., (1995) did not detect E. coli either, but Reitsma et al., (1996) found 
that E. coli O157:H7 survived during manufacture and for more than 60 days of curing of 
cheddar cheese. 
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When comparing the results of aerobic bacteria and coliforms between samples (control 
and treatment) at different stages of maturation, these did not show any significant differences, as 
shown in Table 4.8, which means that treated samples did not diverge on its quality from control 
samples during maturation. 
The aerobic plate count in both samples, control without γ-Oryzanol and treatment with 
γ-Oryzanol, was significantly lower than the counts presented by Reddy et al., (1995), at least 3 
orders of magnitude at all stages of maturation. 
Table 4.8:  Probabilities of significant differences (Pr>|t|) in aerobic bacteria and coliform 
population between control (without γ-Oryzanol) and treatment (with γ-Oryzanol) samples 
during ripening. 
 
Microbial count 
Month 
Aerobic Plate                              Coliform Plate 
0 0.9303 0.5298 
1 0.3248 0.5275 
2 0.0674 0.8253 
3 0.9753 - 
4 0.1003 - 
Probabilities smaller than 0.05 (α) indicate significant differences between samples. 
 Microbial growth patterns for aerobic bacteria, coliforms and yeasts and molds showed 
some significant differences when compared at different ripening times within the same sample.  
When compared between samples at different ripening times, there were no significant 
differences at all, which established that γ-Oryzanol did not affect the microbial growth of 
aerobic bacteria, coliforms, yeast and molds in cheddar cheese during its ripening time.  All 
microbial growth parameters reported tended to decrease during time for the whole experiment 
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(see Figures 4.11 and 4.12 in Appendix A for graphical trend of data in Table 4.7); coliforms did 
not show any growth after the second month. 
4.4 Polymerase Chain Reaction 
 The purpose of performing PCR in the cheese was to determine if the starter culture of 
cheddar cheese was affected by γ-Oryzanol.  The starter culture used in the manufacture of the 
cheddar cheese was a mixture of Lactococcus lactis subsp. cremoris and subsp. lactis.  The 
method used for the PCR was expected to identify and separate both subspecies which was 
achieved as shown in Figure 4.3 (Ward et al., 1998). 
 In Figure 4.3, lanes 1 to 4 are the control samples, lanes 6 to 9 are the treatment samples, 
lanes 5 and 10 are the 100-bp molecular ruler; lanes 1, 3, 6 and 8 are the digested samples with 
the restriction endonuclease enzyme MboII and lanes 2, 4, 7 and 9 are the non-digested samples.  
As indicated in Figure 4.3 the non-digested samples (lanes 2, 4, 7 and 9) show just one bright 
band and that the digested samples (lanes 1, 3, 6 and 8) have two bands which represent both 
subspecies of lactis.   
The blurry bands in the digested samples represent the subsp. cremoris (348-bp) and the 
bright bands represent the subsp. lactis (257-bp) which means that subsp. lactis was in higher 
amount than cremoris in the cheese manufactured for this experiment; these results are similar to 
those of Reddy et al., (1995) who reported that using Lactococcus lactis subsp. lactis and 
Lactococcus lactis subsp. cremoris as starter cultures, the Lactococcus lactis subsp. lactis 
together with Lactobacillus casei were the predominant bacteria. 
 Based on the obtained gel from the PCR, it can be concluded that Lactococcus lactis 
subsp. cremoris (348-bp) and subsp. lactis (257-bp) are both present in the cheddar cheese 
containing γ-Oryzanol after 4 months of maturation. 
 81 
 
Figure 4.3:  Agarose gel (4%) of digested and non-digested products of the Y1-Y2 amplified 
fragment from cheese extraction after 4 months of maturation. 
 
4.5 Aroma Development 
The pattern of aroma development during maturation in both control and treatment 
samples yielded the observation of six peaks in the chromatograms obtained (Tables 4.9 and 
4.10).  The software used to identify the peaks could not accurately identify them but based on 
data reported by Christensen and Reineccius (1995), the six peaks obtained in the experiments 
mostly represent butyric acid, ethyl butyrate, ethyl caproate, 2- or 3- methyl butanal, hexanoic 
acid and propionic acid, respectively, or ethyl esters of these compounds. 
These tables show that there are not significant differences existing when comparing 
different months of ripening in each sample within the same sample with just one exception in 
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peak 2 of the control sample.  The analysis of variance and a post-hoc test pointed out a lack of 
significant differences in aroma development in cheese between months during the ripening 
process within each peak formation.  These values show that changes in the aroma development 
of cheese between months based on the peaks found in the chromatograms were not  
significantly different (p<0.05) for both control and treatment samples. 
Table 4.9:  Means and standard deviations of heights of aroma peaks of control samples without 
γ-Oryzanol at different stages of maturation. 
 
Peak 
 Month 
1                    2                     3                     4                     5                     6 
(Kilocounts) 
0 9.43  
(3.97)a 
24.63 
(6.18)ab 
15.50 
(3.91)a 
15.10 
(5.94)a 
16.15 
(10.39)a 
31.00 
(26.67)a 
1 8.87  
(2.80)a 
8.60  
(2.44)b 
13.40 
(4.91)a 
9.00  
(2.55)a 
10.17 
(2.75)a 
16.60 
(4.81)a 
2 15.23 
(7.68)a 
42.17 
(19.42)a 
20.20 
(8.92)a 
15.70 
(7.25)a 
11.90 
(4.85)a 
10.10 
(1.27)a 
a,b Means within same column followed by different superscripts are significantly different 
(P<0.05). 
Peaks 1, 2, 3, 4, 5 and 6 most probably represent butyric acid, ethyl butyrate, ethyl caproate, 2- 
or 3- methyl butanal, hexanoic acid and propionic acid, respectively. 
 
Table 4.10:  Means and standard deviations of heights of aroma peaks of treated samples with γ-
Oryzanol at different stages of maturation. 
 
Peak 
 Month 
1                    2                     3                     4                     5                     6 
(Kilocounts) 
0 6.87  
(1.60)a 
6.47  
(0.50)a 
9.27  
(1.27)a 
8.93  
(1.85)a 
8.70  
(1.45)a 
8.47  
(0.92)a 
1 5.00  
(0.00)a 
10.25  
(0.0)a 
8.70  
(0.00)a 
5.80  
(0.00)a 
7.00  
(0.00)a 
6.20  
(0.00)a 
2 5.80  
(0.00)a 
31.17 
(23.41)a 
11.87 
(2.76)a 
9.10  
(2.10)a 
6.77  
(1.70)a 
6.80  
(1.44)a 
a Means within same column followed by different superscripts are significantly different 
(P<0.05). 
Peaks 1, 2, 3, 4, 5 and 6 most probably represent butyric acid, ethyl butyrate, ethyl caproate, 2- 
or 3- methyl butanal, hexanoic acid and propionic acid, respectively. 
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The comparison between control and treatment samples at different stages of maturation 
did not show any significant differences either, with one exception, as shown in Table 4.11, 
which was at month 0 from peak 2, but the control samples showed peaks greater than the 
treatment samples.  This means that γ-Oryzanol may have interfered in the flavor and aroma 
development in cheese.  According to Parrado et al., (2003), oryzanol derived from RBO showed 
capacity to inhibit lipid peroxidation and protect protein from oxidation; and according to Nanua 
et al., (2000), a high-oryzanol RBO at 0.1% significantly reduced the oxidation of low-heat 
whole milk powder. 
Table 4.11:  Probabilities of significant differences (Pr>|t|) in heights of aroma peaks between 
control (without γ-Oryzanol) and treatment (with γ-Oryzanol) samples during ripening. 
 
Peak Month 
1                    2                     3                     4                    5                      6 
0 0.3578   0.0357* 0.0982 0.2073 0.4943 0.2677 
1 0.3578 0.6179 0.4945 0.3909 0.4242 0.3280 
2 0.3988 0.5650 0.2425 0.2517 0.1588 0.0801 
*Probabilities smaller than 0.05 (α) indicate significant differences between samples. 
Peaks 1, 2, 3, 4, 5 and 6 most probably represent butyric acid, ethyl butyrate, ethyl caproate, 2- 
or 3- methyl butanal, hexanoic acid and propionic acid, respectively. 
 
 Aroma development pattern for cheddar cheese containing γ-Oryzanol did not show 
significant differences when compared at different ripening times within the same sample, and 
the same results when compared between samples at different ripening times. 
When comparing the means of the different peaks from the chromatograms between 
control and treatment samples, it can be noticed that with just one exception, all the peak heights 
of aroma coming from treatment samples were lower than the control samples at the same 
ripening time.  This may suggest that γ-Oryzanol may have inhibited the growth of bacteria that 
contribute to the odor development or that the antioxidant activity of γ-Oryzanol may have 
inhibited the lipolysis or proteolysis needed in the aroma development in cheddar cheese until 
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certain point even that statistically speaking there were not significant differences.  There is no 
congruent tendency of peak heights for the main six compounds found to produce aroma in 
cheddar cheese, some increased during time and some others decreased (see Figures 4.13 to 4.18 
in Appendix A for graphical trend of data in Tables 4.9 and 4.10). 
4.6 Oryzanol Retention 
 In order to compare control and treatment samples, both were run in HPLC even though 
the control did not have γ-Oryzanol.  The control samples did not show any peak in the 
chromatograms, and the treatment samples showed two joined peaks (see Figure 4.19 in 
Appendix A for an example of chromatograms obtained).  The results of γ-Oryzanol retained in 
the cheese are shown in the Table 4.12; this table also shows the significant differences within 
treatments at different maturation times.  ANOVA and a post-hoc test indicated that γ-Oryzanol 
retention analysis had significant differences (p<0.0001). 
Table 4.12:  Means and standard deviations of γ-Oryzanol retained in treated cheese at different 
stages of maturation (per serving size). 
 
Month γ-Oryzanol retained (mg/28g) 
0 181.41 (5.94)a 
1 99.30 (0.00)b* 
2 172.36 (10.94)a 
3 129.85 (21.67)b 
a,b Means followed by different superscripts are significantly different (P<0.05). 
* Only one sample was obtained. 
 
 The γ-Oryzanol retained showed significant differences between following months.  The 
results seem to show a tendency to decrease in time during maturation but without any clear 
pattern (see Figure 4.20 in Appendix A for graphical tendency of data in Table 4.12 compared to 
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the target value) which could be due to a poor homogenization of γ-Oryzanol at the time of 
manufacture of the cheese or that the analytical method was not accurate nor precise.  It was 
visually evident that the cheddar cheese containing γ-Oryzanol was not well mixed since white 
spots could be seen spread all over the cheese, some were bigger than others. 
 Even if the results of γ-Oryzanol retention in cheese do not show any expected values, it 
is very important to keep in mind that the target concentration of γ-Oryzanol added in cheese was 
100mg per serving size of cheddar cheese (28g).  The results presented in Table 4.12 show that 
the γ-Oryzanol was very well retained in the cheese and that there was some loss of it during 
ripening but still above 100mg/28g of cheese as expected. 
4.7 Moisture Content 
Table 4.13 presents the results of moisture content of both control and treatment samples 
together with significant differences between ripening times within the same sample.  The 
analysis of variance and a post-hoc test indicated an existence of significant differences 
(p<0.0378 for control samples and p<0.0026 for treatment samples) in moisture contents in 
cheese during the ripening process.  These values show that changes in moisture content of 
cheese between some months were without exception significantly different (p<0.05) for both 
control and treatment samples; between some other months, there were no significant differences 
at all. 
The statistical analysis performed to compare the means between samples (control and 
treatment) produced the data presented in Table 4.14.  The comparison of means in moisture 
content between control and treatment samples look very similar and with similar behaviors, 
with a slight decrease during ripening process, as it can been seen in Table 4.13, and the 
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probabilities seen in Table 4.14 show that there are not significantly differences between control 
and treatment samples at different ripening times. 
Table 4.13:  Means and standard deviations of moisture content in control (without γ-Oryzanol) 
and treatment (with γ-Oryzanol) samples at different stages of maturation. 
 
Moisture content (%) 
Month 
Control                                         Treatment 
0 44.55 (0.89)a 43.86 (0.49)ab 
1 43.83 (0.09)ab 44.58 (0.42)a 
2 41.65 (0.96)b 40.74 (0.40)c 
3 42.45 (0.18)ab 42.45 (0.32)b 
a,b,c Means within same column followed by different superscripts are significantly different 
(P<0.05). 
 
Table 4.14:  Probabilities of significant differences (Pr>|t|) in moisture content between control 
(without γ-Oryzanol) and treatment (with γ-Oryzanol) samples during ripening. 
 
Month Probability (Pr>|t|) 
0 0.4353 
1 0.1311 
2 0.3415 
3 1.0000 
Probabilities smaller than 0.05 (α) indicate significant differences between samples. 
Albeit there were some significant differences in moisture content between months 
within each sample and there were no significant differences between control and treatment 
samples, it can be concluded that γ-Oryzanol did not affect the moisture content of cheddar 
cheese in a significant way (see Figure 4.21 in Appendix A for graphical trend of Table 4.13).  
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The maximum moisture content in cheddar cheese is 39 percent by weight (USFDA, 2002), both 
samples have a moisture content of 39% which means that something was wrong with the 
process used or that the pressing step should have been done longer or with higher pressure. 
4.8 Free Fatty Acid Profile 
 The concentration of each free fatty acid was calculated based on the chromatogram 
peaks and the software the GC was equipped with, the results of the free fatty acid profile for 
both control and treatment samples are presented in Tables 4.29 and 4.30 in Appendix A. 
 ANOVA and a post-hoc test indicated that there were significant differences (p<0.05) in 
the analysis of some free fatty acids, such as C4:0, C8:0, C14:0, C16:0, C18:0 and C18:2, for 
both samples; C6:0, C12:0, C18:1 and C18:3 gave significant differences just in control samples, 
C16:0 just in treatment samples, and C10:0 did not show any differences at all. 
 Tables 4.29 and 4.30 also show the significant differences between months within the 
same sample, and it can be seen that there are significant differences between some contiguous 
months and in some other contiguous months this differences do not exist. 
 The free fatty acid profile did not show any pattern during ripening when comparing the 
free fatty acid content between ripening times, but it did show that the long chain free fatty acids 
are more concentrated than the middle chain and short chain fatty acids. 
 When comparing the free fatty acid profile between samples (control and treatment) at 
different stages of the maturation, the significant differences are tabulated as probabilities in 
Table 4.15.  It can be seen from this table that there were no significant differences in any pair-
wise comparison between control samples and treatment samples at any time. 
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Table 4.15:  Probabilities of significant differences (Pr>|t|) in texture parameters between control (without γ-Oryzanol) and treatment 
(with γ-Oryzanol) samples during ripening. 
 
Free fatty acid 
Month 
C4:0      C6:0         C8:0       C10:0     C12:0      C14:0      C14:1      C16:0      C16:1      C18:0       C18:1     C18:2      C18:3 
0 - 0.5239 0.4073 0.3482 0.4507 0.2824 0.5956 0.5785 0.9613 0.3936 0.6372 0.2154 0.5477 
1 - 0.6726 0.3283 0.5725 0.1388 0.0539 0.4665 0.1139 0.6105 0.2348 0.3159 0.3508 0.5444 
2 - - 0.4395 0.3833 0.2756 0.2165 0.9440 0.6235 0.4975 0.6491 0.5094 0.6152 0.4961 
3 0.9017 0.7462 0.7955 0.7576 0.1225 0.6861 0.7460 0.5916 0.2692 0.6383 0.6398 0.9670 0.4828 
Probabilities smaller than 0.05 (α) indicate significant differences between samples. 
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 Results of the free fatty acid profile show too much variability, maybe due to the changes 
in cheese quality during the ripening process due to γ-Oryzanols’ presence.   γ-Oryzanol can be 
interfering with the GC analysis in some way which does not allow the quantification of the free 
fatty acids efficiently or changing the interactions between the solvent and the lipid extract. 
 In this experiment, the total FFA content increased during the first month of maturation 
but then decreased in the following two months (Figure 4.4).  It is known from another study that 
the total FFA content of cheese made from raw milk and pasteurized milk increases from day 1 
to day 60 (Buffa et al., 2001) which puts in contradiction both studies.   
Figure 4.4:  Total free fatty acid content in cheese samples during ripening per Kg of cheese. 
 The main FFA observed in the cheese during its maturation were myristic (C14:0), 
palmitic (C16:0), stearic (C18:0) and oleic (C18:1) acids (Table 4.16), representing together 
approximately 80% of total FFA content, coinciding with Buffa et al. in 2001, and confirming 
that the percentages of the FFA profile were similar in cheddar cheese containing γ-Oryzanol to 
normal cheddar cheese evaluated in other studies. 
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Another explanation for the decrease in FFA during time could be due to the fact that γ-
Oryzanol had to do with this free fatty acid behavior during ripening affecting the tendency of 
FFA to increase during time.  This seems to be the most logical explanation since γ-Oryzanol is 
known to have a good antioxidant activity (Xu et al., 2001) which could have diminished the 
lipolysis in the cheese and the subsequent increase in free fatty acids.  However, the control 
samples also showed this behavior which does not support the explanation above. 
Table 4.16:  Percentages (%) of free fatty acids (FFA) in cheese samples during ripening. 
Month 0 1 2 3 
FFA C T C T C T C T 
c4:0 0.00 0.00 0.00 0.00 0.00 0.00 6.14 6.08 
c6:0 5.95 6.50 16.49 17.70 0.00 0.00 1.20 1.19 
c8:0 2.39 2.33 3.25 2.83 2.95 2.30 0.76 0.75 
c10:0 1.46 1.46 1.79 0.91 1.69 1.33 1.80 1.77 
c12:0 3.32 3.22 2.75 2.76 3.83 3.01 1.70 3.79 
c14:0 6.92 8.16 3.46 3.37 4.57 3.56 9.46 9.25 
c14:1 1.44 1.11 1.26 0.14 1.72 1.44 1.47 1.45 
c16:0 16.90 16.11 12.92 12.71 13.38 14.10 30.76 29.78 
c16:1 0.03 0.02 0.52 0.62 5.79 0.71 1.10 1.94 
C18:0 54.87 54.11 40.51 41.42 44.92 46.03 13.98 13.61 
c18:1 2.41 1.94 1.90 2.08 2.64 12.84 26.99 26.29 
c18:2 1.69 1.90 0.95 1.05 13.17 14.27 3.59 3.50 
c18:3 2.63 3.13 14.21 14.40 5.35 0.41 1.05 0.60 
C: control samples, T: treatment samples and c: carbon atoms in FFA. 
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 From Table 4.16, it can also be seen the differences existing between saturated free fatty 
acids and unsaturated free fatty acids in the cheese throughout the whole ripening process.  The 
main FFA observed are mostly saturated (no double bonds between carbon atoms) with 
exception of oleic acid which is a monosaturated fatty acid. 
 The only conclusion that can be reached from all these analysis and results is that both 
control and treatment samples of cheddar cheese in this experiment presented a similar FFA 
profile in percentages basis compared to data found in other experiments (Buffa et al., 2001; 
Lindsay, 1982), and that the effects of γ-Oryzanol did not have any significant effects in the 
quality of cheddar cheese during maturation. 
 Fat plays an essential part in the flavor of cheese, albeit an indirect part, and the most 
important flavor compounds originating from the fat are the free fatty acids formed by lipolysis 
(Walstra et al., 1999) which can explain part of the aroma development in cheese.  The free fatty 
acids at the first month of maturation may have influenced more the aroma development of 
cheese than at the other times since at this stage was where the highest amount of free fatty acids 
was present.   
The free fatty acids cause a somewhat pungent flavor.  Probably, the distribution of 
aroma compounds over fat and aqueous phases enhances a balanced flavor (Walstra et al., 1999).  
This distribution was mostly influenced by the long chain fatty acids rather than small chain fatty 
acids at all times of maturation.  
4.9 Consumer Study 
4.9.1 R-Index 
 For the traditional R-Index, the data obtained from the questionnaire was: consumer was 
certain that the sample was the treatment (S), that perhaps the sample was the treatment but not 
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sure (S?), that perhaps the sample was the control but not sure (N?) or that definitely the sample 
was the control (N). 
The calculated R-Indices and the critical R-Indices for the traditional method, including 
the frequencies of S, S?, N? and N for all the attributes evaluated by the traditional R-Index 
which were the overall appearance, overall color, odor, taste and overall texture are condensed in 
the Table 4.17. 
Table 4.17:  R-Index values of traditional method for the consumer study in cheese containing γ-
Oryzanol with the attributes evaluated. 
 
Different Same 
Attribute Sample 
S S? N? N 
R-Index 
(%) 
Critical 
R-Index 
(%) 
Overall 
Appearance 
485 (S) 
705 (N) 
69 
16 
10 
4 
10 
23 
10 
56 
82.1 59.7 
Overall 
Color 
485 (S) 
705 (N) 
34 
10 
14 
5 
17 
18 
34 
66 
69.4 59.7 
Odor 
485 (S) 
705 (N) 
37 
13 
16 
9 
20 
28 
24 
47 
68.1 59.7 
Taste 
485 (S) 
705 (N) 
68 
28 
13 
14 
8 
21 
9 
36 
73.7 59.7 
Overall 
Texture 
485 (S) 
705 (N) 
59 
19 
12 
8 
13 
28 
13 
44 
75.3 59.7 
485 (S) = cheese containing γ-Oryzanol; 705 (N) = cheese without γ-Oryzanol; S= different sure; 
S?= different unsure; N?= same unsure; N= same sure. 
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As seen in the Table 4.17, without any exception, the calculated R-Indices for all the 
attributes evaluated with the traditional method (overall appearance, overall color, odor, taste and 
overall texture) were greater than the critical R-Index value of 59.7 which means that the 
consumer significantly noticed a difference between control and treatment samples not by 
chance.  The most discriminatory attributes were overall appearance (82.1%) and overall texture 
(75.3%) which tells that consumer noticed better differences in these attributes than in the others, 
especially for the overall appearance. 
 The data obtained for calculation of the R-Index by the bipolar method are tabulated in 
the Table 4.18.  From the Table 4.18, the consumers noticed that the treatment samples (S) were 
more yellow than the control samples (N), they also were able to indicate that the treatment 
sample was harder than the control sample. 
Table 4.18:  Frequencies of attributes evaluated with R-Index by the bipolar method and 
directions of the differences. 
 
More Same Less Total 
Attribute Sample 
S+ S+? N? N S- S-? More Less 
R-Index to 
be used 
Yellowness 
485 (S) 
705 (N) 
27 
15 
13 
9 
12 
14 
21 
48 
19 
9 
5 
3 
40 
24 
24 
12 
More 
Hardness 
485 (S) 
705 (N) 
40 
14 
21 
9 
12 
22 
13 
41 
9 
9 
5 
5 
61 
23 
14 
14 
More 
Chewiness 
485 (S) 
705 (N) 
22 
13 
8 
5 
14 
23 
17 
43 
24 
9 
13 
5 
30 
18 
37 
14 
More/Less 
485 (S) = cheese containing γ-Oryzanol; 705 (N) = cheese without γ-Oryzanol; S+= more sure; 
S+?= more unsure; N?= same unsure; N= same sure; S-= less sure; S-?= less unsure. 
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The calculated R-Indices and the critical R-Indices for the bipolar method with positive 
direction, including the frequencies of S+, S+?, N? and N for the yellowness and hardness are 
condensed in the Table 4.19. 
For the chewiness, which did not show any direction for the R-Index, the calculated R-
Index and critical R-Index combining S+ with S- and S+? with S-? are in the Table 4.20. 
The calculated R-Indices observed in Tables 4.19 and 4.20 for all the attributes evaluated 
with the bipolar method, (yellowness, hardness and chewiness) were greater than the critical R-
Indices values which means that the consumer, with a significant difference, noticed a difference 
between control and treatment samples not by chance (probability). 
Table 4:19:  R-Index values of bipolar method for the consumer study in cheese containing γ-
Oryzanol with the attributes evaluated with positive direction. 
 
More Same 
Attribute Sample 
S+ S+? N N? 
R-Index (%) 
more 
Critical R-
Index (%) 
Yellowness 
485 (S) 
705 (N) 
27 
15 
13 
9 
12 
14 
21 
48 
66.1 59.5 
Hardness 
485 (S) 
705 (N) 
40 
14 
21 
9 
12 
22 
13 
41 
73.9 58.8 
485 (S) = cheese containing γ-Oryzanol; 705 (N) = cheese without γ-Oryzanol; S+= more sure; 
S+?= more unsure; N?= same unsure; N= same sure. 
 
It can also be said that consumers noticed more presence of the attribute in the treatment 
sample than in the control sample for the yellowness and hardness, and even if consumers could 
notice differences in the chewiness between the control and treatment samples, they were not 
able to notice whether these differences were more or less of the attribute in question. 
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The most discriminatory attribute by the bipolar method was the hardness of the samples 
which tells that consumer noticed better differences in this attribute than in the others. 
Table 4:20:  R-Index values of bipolar method for the consumer study in cheese containing γ-
Oryzanol with the attributes evaluated with no direction (more/less). 
 
Combined Same 
Attribute Sample S+,  
S- 
S+?, 
S? 
N N? 
R-Index (%) 
Critical R-
Index (%) 
Chewiness 
485 (S) 
705 (N) 
22+24
13+9 
8+13 
5+5 
14 
23 
17 
43 
69.0 58.2 
485 (S) = cheese containing γ-Oryzanol; 705 (N) = cheese without γ-Oryzanol; S+= more sure; 
S+?= more unsure; N?= same unsure; N= same sure; S-= less sure; S-?= less unsure. 
 
As a conclusion of the R-Index study in the cheddar cheese containing γ-Oryzanol 
(treatment), consumers were able to differentiate between the treatment and the control samples 
(normal cheddar cheese) based on overall appearance, overall color, odor, taste, overall texture, 
yellowness, hardness and chewiness.  The most discriminating attribute of the cheese by 
consumers was the overall appearance, and the least discriminating was the yellowness. 
4.9.2 The McNemar Test 
 Table 4.21 describes counts, frequencies and percentages of purchase intent responses by 
consumers before and after knowing the potential health benefits they could get from the γ-
Oryzanol in cheddar cheese.  These data were used to calculate the difference in proportions, the 
probability in purchase intent, the statistic χ2, the estimated standard error and the confidence 
interval by the McNemar test (see Appendix D for the codes in SAS). 
Table 4.22 shows data obtained from the McNemar test.  It can be seen from this table 
that a significant difference existed between the two responses, with a χ2 value of 19.2 which is 
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greater than the critical χ2df 1 of 3.84.  The decision of buying the cheddar cheese containing γ-
Oryzanol was influenced by the fact that consumers had been informed about the potential health 
benefits of the product. 
Table 4.21:  Purchase intent responses for cheddar cheese containing γ-Oryzanol before and 
after consumers were informed that the product contained a potentially health promoter 
compound. 
 
Purchase intent after knowing of health benefits Purchase intent 
(before) Yes No Total 
Yes 18 (18.18%) 1 (1.01%) 19 (19.19%) 
No 22 (22.22%) 58 (58.59%) 80 (80.81%) 
Total 40 (40.40%) 59 (59.60%) 99 (100.00%) 
 
Table 4.22:  Variables obtained in the McNemar test. 
Difference of 
proportions 
95% confidence 
interval for the 
difference 
Statistic χ2 Pr> χ2 
0.21 (0.13,0.30) 19.2 <0.0001 
 
 The 95% confidence interval for the difference in proportions was calculated in order to 
obtain a better understanding of the association between the two questions’ responses (Pavon, 
2003).  This confidence interval for the cheese explains that the probability that consumers 
would buy the product after they had been informed about the potential health benefits was 0.13 
to 0.30 times higher than the probability of consumers buying it before they had been informed 
about the health benefits.  In conclusion, it can be said that there was a significant positive 
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increase in the purchase intent of cheddar cheese containing γ-Oryzanol after consumers had 
been informed about the health benefits of this compound. 
4.9.3 Consumer Acceptance Test 
 Table 4.23 reports the mean scores and ANOVA results for the acceptability of overall 
appearance, smoothness of color, odor/aroma, taste, overall texture/mouthfeel and overall liking 
of the control sample and the treatment sample containing γ-Oryzanol (see Appendix D for the 
codes in SAS).  The analysis of variance and a post-hoc test indicated an existence of differences 
in acceptability of odor/aroma, taste, overall texture/mouthfeel and overall liking of both 
samples. 
Table 4.23:  Means, standard deviations and analysis of variance for acceptability attributes of 
the control (without γ-Oryzanol) and treatment (with γ-Oryzanol) samples. 
 
Cheese sample 
Attribute 
Control Treatment 
Pr>F 
Overall Appearance 6.04 (1.73)a 5.62 (2.00)a 0.1146 
Smoothness of color 6.22 (1.65)a 5.82 (1.75)a 0.0988 
Odor/Aroma 6.21 (1.63)a 5.24 (1.50)b <0.0001 
Taste 5.52 (2.16)a 4.04 (1.94)b <0.0001 
Mouthfeel 5.84 (1.97)a 4.68 (1.72)b <0.0001 
Overall Liking 5.60 (1.79)a 4.07 (1.82)b <0.0001 
a,b Means within same row followed by different superscripts are significantly different (P<0.05). 
 
 The scores in Table 4.23 show, without any exception, that for all the attributes, the 
consumers gave lower scores to the treatment samples than to the control samples.  This means 
that they liked the cheddar cheese containing γ-Oryzanol less than the normal cheddar cheese.  
These differences in the scores between both samples are significant for the aroma, taste, 
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mouthfeel and overall liking but not for the overall appearance and color.  Therefore, consumers 
liked in the same scale the overall appearance and color, but they differentiate between samples 
when evaluating the aroma, taste, mouthfeel and overall liking. 
 Multivariate analysis of variance (MANOVA) indicated that both the control and the 
treatment samples were significantly different when the effects sensory acceptability scores were 
considered simultaneously with probabilities of less than 0.0001 for all, Wilks’ Lambda, Pillai’s 
Trace, Hotelling-Lawley Trace and Roy’s Greatest Root statistic.  These probabilities prove the 
results obtained from ANOVA. 
 To get a better understanding of such a difference, Descriptive Discriminant Analysis 
was performed.  The first dimension of pooled within canonical structure (CAN 1) were used to 
identify discriminating attributes; these values are shown in Table 4.24. 
Table 4.24:  Canonical structure of attributes describing the cheese samplesa. 
Attribute CAN 1 
Overall Appearance 0.21 
Smoothness of Color (yellowness) 0.24 
Odor/Aroma 0.64* 
Taste 0.76* 
Overall Texture/Mouthfeel 0.66* 
Overall Liking 0.88* 
a CAN1 is based on pool within group variances. 
* Discriminating sensory attributes. 
 
 The canonical coefficients seen in Table 4.24 indicate that overall appearance and 
smoothness of color were not critical discriminant attributes in the sensory evaluation of cheese, 
whereas, aroma, taste, mouthfeel and overall liking were discriminant attributes with overall 
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liking being the most discriminant attribute with the highest canonical coefficient of 0.88 and 
overall appearance the least discriminant with a canonical coefficient of 0.21.  This means that 
overall liking is the attribute giving more contribution to the sensory evaluation of cheese, 
followed by taste, then mouthfeel and aroma. 
 For the attributes evaluated with a yes/no scale in the questionnaire, the data is tabulated 
in the Table 4.25, from which, part was used for McNemar test and other for a logistic analysis. 
Table 4.25:  Frequencies and percentages of attributes evaluated in control (without γ-Oryzanol) 
and treatment (with γ-Oryzanol) cheese samples with a yes/no scale. 
 
Sample 
Control                                         Treatment Question 
Yes No Yes No 
Did you detect undesirable 
bitterness aftertaste? 
45 (50.00%) 45 (50.00%) 74 (81.32%) 17 (18.68%) 
Is this product acceptable? 74 (74.75%) 25 (25.25%) 36 (36.73%) 62 (63.27%) 
Would you buy this product if 
it were commercially 
available? 
56 (56.00%) 44 (44.00%) 19 (19.00%) 81 (81.00%) 
Would you buy this product if 
it contained oryzanol, an 
antioxidant and potential 
cholesterol reducing 
compound from rice bran? 
66 (66.67%) 33 (33.33%) 40 (40.40%) 59 (59.60%) 
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 The logistic analysis performed using the acceptability of the product as a response 
variable produced the point estimates and probabilities presented in Table 4.26 when comparing 
with all sensory attributes. 
 The highest point estimate from the logistic analysis in Table 4.26 is the overall liking 
and with significant difference; the odds ratio estimate of overall liking has a value of 2.85 which 
means that this attribute is the most important for changing the acceptability of the product, and 
if the overall liking score increased 1.0 unit from the 9-point hedonic scale, the probability of the 
product to be acceptable would increase 2.85 times. 
Table 4.26:  Odds ratio estimates and probabilities (Pr>χ2) for logistic regression models using 
acceptability as a response variable. 
 
Attribute Pr>χ2 Odds ratio estimate 
Overall Appearance 0.1020 1.38 
Smoothness of color 0.0893 0.70 
Odor/Aroma 0.6598 0.92 
Taste 0.7981 1.06 
Overall Texture/Mouthfeel 0.5187 1.13 
Overall Liking <0.0001* 2.85 
* Probabilities smaller than 0.05 (α) indicate significant differences. 
 When using the responses in the questionnaire of buying the product if it were 
commercially available (before consumer are informed of the potential health benefits of the 
product) as a response variable for the logistic analysis of the product, the data is presented in the 
Table 4.27 with point estimates and probabilities when all sensory attributes are evaluated. 
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 From the Table 4.27, it can be seen that overall liking and overall texture/mouthfeel have 
the highest point estimates with significant differences.  This means that these attributes are the 
most important for changing the purchase intent of the product; if the overall liking score 
increased 1.0 unit from the 9-point hedonic scale, the probability of the product to be purchased 
would increase 3.39 times, and if the overall texture/mouthfeel score augmented 1.0 unit, the 
probability of the product to be purchased would increase 2.24 times. 
Table 4.27:  Odds ratio estimates and probabilities (Pr>χ2) for logistic regression models using 
purchase intent before knowing about health benefits as a response variable. 
 
Attribute Pr>χ2 Odds ratio estimate 
Overall Appearance 0.1365 1.43 
Smoothness of color 0.0673 0.59 
Odor/Aroma 0.1345 0.71 
Taste 0.6421 1.12 
Overall Texture/Mouthfeel 0.0036* 2.24 
Overall Liking 0.0005* 3.39 
* Probabilities smaller than 0.05 (α) indicate significant differences. 
 After knowing the prediction in purchase intent of potential consumers before they have 
been informed of the health benefits of the product, knowing which attributes significantly 
differentiate and predict the purchase intent and at what ratio these changes after consumers have 
been informed of the health benefits of the product completes the logistic analysis. 
 When using the responses in the questionnaire of buying the product if it were 
commercially available (after consumer have been informed of the potential health benefits of 
the product) as a response variable for the logistic analysis of the product, the data is presented in 
the Table 4.28 with point estimates and probabilities when all sensory attributes are evaluated. 
 102
Table 4.28:  Odds ratio estimates and probabilities (Pr>χ2) for logistic regression models using 
purchase intent after knowing about health benefits as a response variable. 
 
Attribute Pr>χ2 Odds ratio estimate 
Overall Appearance 0.1657 1.24 
Smoothness of color 0.9793 1.00 
Odor/Aroma 0.5992 1.08 
Taste 0.2920 1.21 
Overall Texture/Mouthfeel 0.7400 0.95 
Overall Liking 0.0316* 1.58 
* Probabilities smaller than 0.05 (α) indicate significant differences. 
 The highest point estimate from the logistic analysis in Table 4.28 is the overall liking 
followed by the overall appearance, but just the former shows significant differences, thus 
overall appearance is not useful; the odds ratio estimate of overall liking has a value of 1.58 
which means that this attribute is the most important for changing the purchase intent of the 
product after consumers have been informed of the potential health benefits of it; if the overall 
liking score increased 1.0 unit from the 9-point hedonic scale, the probability of the product to be 
acceptable would increase 1.58 times after knowing the health benefits of it. 
 If the estimated odd ratios used to predict consumer purchase intent that were identified 
for buying the product if it were commercially available for both before and after consumer have 
been informed of the potential health benefits of the product are compared to each other, it can 
be seen that just the attribute overall liking is common for both purchase intents (before and 
after), and that the mouthfeel is not an important predictor for purchase intent after knowing the 
health benefits.  This leaves the overall liking attribute as the only predictor that is critical in the 
purchase intent. 
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 The odds point estimate for predicting the purchase intent before knowing of the health 
benefits is 3.39 and after consumers are informed of the potential health benefit of the product, it 
decreases to 1.58, which shows that consumers are willing to compromise the overall liking of 
the cheese merely to get the health benefits of the product. 
 The overall liking score for the cheese containing γ-Oryzanol was 5.6 (between like 
slightly and neither like nor dislike), and the prediction for purchase intent would be that 
consumers are willing to go to an overall liking score of 3.5 (between dislike moderately and 
dislike slightly) and still purchase the cheese in order to get the health benefits of it. 
 The attributes were analyzed individually to predict changes in acceptability and 
purchase intent in case all attributes together did not show any significant responses.  All of them 
showed significant differences when compared with the acceptability and with buying intent 
before and after consumers know about the health benefits of the product. 
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CHAPTER 5. CONCLUSIONS 
Color analysis showed changes in the quality of the cheese during ripening.  Some were 
significant some others were not significant, but there is not a clear tendency or pattern. 
Texture profile analysis showed that there were changes in the quality of the cheese 
during maturation for control and treatment samples, but that there were no significant changes 
when γ-Oryzanol was added to cheese and compared to a control. 
Microbial growth based on aerobic bacteria presented non significant changes for all the 
period of evaluation of the cheese; however, coliform counts showed differences because there 
was no growth of coliforms after the second month of evaluation. 
Aroma development in cheese did not present any significant differences during 
maturation nor between control and treatment samples at different stages of ripening, but the 
peaks for the control samples were slightly larger than the treatment samples.  The aroma 
development may have been inhibited by the antioxidant activity of γ-Oryzanol decreasing the 
lypolisis, proteolysis precursors of part of the flavor and aroma in cheese. 
The polymerase chain reaction confirmed that Lactococcus lactis subsp. cremoris and 
subsp. lactis are both present in the cheddar cheese containing γ-Oryzanol. 
Even if the results obtained of γ-Oryzanol in cheese do not show any clear pattern, γ-
Oryzanol was very well retained in the cheese and there were some losses of it during ripening 
but the target of 100mg per serving size of cheddar cheese (28g) was reached. 
γ-Oryzanol did not affect the moisture content of cheddar cheese in a significant way.  
The manufacture procedure used to make the cheddar cheese yielded a product that will not 
comply the FDA regulations because it must have a maximum moisture content in cheddar 
cheese is 39 percent by weight which is not the case for the cheese made for this experiment.  
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This situation may limit the potential use of γ-Oryzanol in cheese as a functional ingredient or 
the manufacturing procedure used. 
 The free fatty acid profile of both control and treatment samples of cheddar cheese in this 
experiment did not show any pattern or behavior that can give some idea of the effects of γ-
Oryzanol in the cheese.  The only thing that can be said is that the FFA profile obtained in this 
experiment presented a similar FFA profile in percentages basis when compared to data found in 
other experiments.  Therefore, the effects of γ-Oryzanol did not make any significant 
differentiation in the quality of cheddar cheese during maturation. 
ANOVA and post-hoc test determined that all quality parameters evaluated in control and 
treatment cheese samples had significant differences during maturation.  However, the two-
sample t-test indicated that in most cases, γ-Oryzanol did not produce significant differences in 
the quality of the cheddar cheese. 
 Both R-Index methods (traditional and bipolar) produced some important facts about the 
sensory evaluation of cheddar cheese containing γ-Oryzanol.  First, the consumer, with a 
significant difference noticed a difference between control and treatment samples not by any 
chance (probability); the most discriminatory attributes were overall appearance and overall 
texture which tells that consumer noticed better differences in these attributes than in the others, 
especially for the overall appearance.  The consumers noticed that the treated samples were more 
yellow than the control; they also were able to differentiate that the treatment sample was harder 
than the control sample; and last, but not less important, that for the chewiness of the samples, 
the consumers were not able to differentiate between control and treatment samples. 
It can also be said that consumers noticed more presence of the attribute in the treatment 
sample than in the control sample for the yellowness and hardness.  Also, even if consumers 
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could notice differences in the chewiness between the control and treatment samples, they were 
not able to notice whether these differences were more or less of the attribute in question.   
The most discriminatory directional attribute was the hardness of the samples which tells 
that consumer noticed better positive or negative differences in this attribute than in the others.  
The most discriminating attribute of all was the overall appearance, and the least discriminating 
was the yellowness. 
In other words, consumers were able to differentiate between the treatment containing γ-
Oryzanol and the control (normal cheddar cheese), based on overall appearance, overall color, 
odor, taste, overall texture, yellowness, hardness and chewiness, but mainly with overall 
appearance, texture, taste and hardness. 
By means of the McNemar test, it was found out that the decision of buying the cheddar 
cheese containing γ-Oryzanol was influenced with the fact that consumers had been informed 
about the potential health benefits of the product.  This test also found out that the probability 
consumers would buy the product after they had been informed about the health benefits of it 
was 0.13 to 0.30 times higher than the probability of consumers buying it before they had been 
informed about the health benefits.  So, there was a significant positive increase in the purchase 
intent of cheddar cheese containing γ-Oryzanol after consumers had been informed about the 
health benefits of this compound. 
 The consumer acceptance test of cheese containing γ-Oryzanol indicated an existence of 
significant differences in the attributes of odor/aroma, taste, overall texture/mouthfeel and 
overall liking of both samples but not for overall appearance and smoothness of color. 
 Consumers gave lower scores to the cheese containing γ-Oryzanol than to the control 
samples which means that they liked less the cheddar cheese with extra health benefits with γ-
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Oryzanol than the normal cheese.  Consumers liked at the same level the overall appearance and 
color of the cheeses, but they differentiated between sample when evaluating the aroma, taste, 
mouthfeel and overall liking. 
 From the DDA, it was found out that the overall liking attribute was the most 
discriminant attribute for cheese which suggests that this attribute is contributing more to the 
sensory evaluation of cheese, followed by taste, then mouthfeel and aroma.  The least 
discriminant attribute for cheese was the overall appearance meaning that this attribute does not 
contribute in anything for the sensory evaluation of it. 
 The logistic regression analysis has shown overall liking is the most important attribute 
for changing the acceptability of the product, and if the overall liking scores increased 1.0 unit 
from the 9-point hedonic scale, the probability of the product to be acceptable would increase 
2.85 times.   
 Evaluating the purchase intent before consumers are informed of the health benefits of 
the product determined that overall liking is still the most important attribute for changing the 
purchase intent, followed by overall texture/mouthfeel; however, if the overall liking score 
increased 1.0 unit from the 9-point hedonic scale, the probability of the product to be purchased 
would increase 3.39 times which is higher than 2.85 for acceptability.  Also, if the overall 
texture/mouthfeel score augmented 1.0 unit, the probability of the product to be purchased would 
increase 2.24 times.   
 When evaluating the purchase intent after consumers are informed of the health benefits 
of the product, the logistic regression determined that overall liking was still the most important 
attribute for changing the purchase intent, followed by the overall appearance.  However, only 
overall liking shows significant differences so overall appearance is not useful; and if the overall 
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liking score increased 1.0 unit from the 9-point hedonic scale, the probability of the product to be 
acceptable would increase 1.58 times after knowing the health benefits of it.   
 This value of 1.58 is smaller than the values when purchase intent before knowing about 
the health benefits was evaluated (3.39), which shows that consumers are willing to compromise 
the overall liking of the cheese merely to get the health benefits of the product. 
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APPENDIX A. FIGURES AND TABLES OF ANALYSES RESULTS 
a. TEXTURE 
Figure 4.5:  Hardness of control and treatment cheese samples during maturation. 
 
 
Figure 4.6:  Cohesiveness of control and treatment cheese samples during maturation. 
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Figure 4.7:  Gumminess of control and treatment cheese samples during maturation. 
 
 
Figure 4.8:  Chewiness of control and treatment cheese samples during maturation. 
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Figure 4.9:  Springiness of control and treatment cheese samples during maturation. 
 
 
Figure 4.10:  Resilience of control and treatment cheese samples during maturation. 
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b. MICROBIAL GROWTH 
 
Figure 4.11:  Total aerobic bacteria growth in control and treatment cheese samples during 
ripening. 
 
 
 
Figure 4.12:  Total coliform growth in control and treatment cheese samples during maturation. 
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c. AROMA DEVELOPMENT 
 
 
Figure 4.13:  Aroma development of peak 1 in control and treatment samples during ripening. 
 
 
Figure 4.14:  Aroma development of peak 2 in control and treatment samples during ripening. 
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Figure 4.15:  Aroma development of peak 3 in control and treatment samples during ripening. 
 
 
Figure 4.16:  Aroma development of peak 4 in control and treatment samples during ripening. 
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Figure 4.17:  Aroma development of peak 5 in control and treatment samples during ripening. 
 
 
Figure 4.18:  Aroma development of peak 6 in control and treatment samples during ripening. 
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d. ORYZANOL RETENTION 
 
 
 
 
 
Control 
Treatment 
Figure 4.19:  Chromatography of oryzanol in cheese. 
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Figure 4.20:  Oryzanol retention in treatment samples during maturation (Target=100mg). 
 
 
e. MOISTURE CONTENT 
Figure 4.21:  Moisture content in control and treatment cheese samples during ripening. 
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f. FREE FATTY ACID PROFILE 
Table 4.29:  Means and standard deviations of main free fatty acids in control samples of cheese without γ-Oryzanol at different 
stages of maturation. 
 
Free fatty acid (mg/Kg)* 
Month 
C4:0      C6:0         C8:0       C10:0     C12:0      C14:0      C14:1      C16:0      C16:1      C18:0       C18:1     C18:2      C18:3 
0 
0.00 
(0.00)b 
8.53 
(2.77)b 
3.39 
(0.38)ab
2.06 
(0.22)a 
4.71 
(0.56)b 
9.82 
(1.44)a 
2.00 
(0.46)a 
23.94 
(2.64)ab 
0.04 
(0.01)a 
77.76 
(9.44)ab 
3.42 
(0.38)b 
2.38 
(0.01)a 
3.66 
(0.68)b 
1 
0.00 
(0.00)b 
0.00 
(0.00)b 
2.84 
(0.11)ab
1.63 
(0.05)a 
3.70 
(0.11)bc
4.41 
(0.16)b 
1.66 
(0.02)a 
37.25 
(4.90)a 
1.53 
(0.49)a 
117.79 
(24.24)a 
5.48 
(0.78)b 
2.78 
(0.67)a 
42.08 
(15.90)a
2 
0.00 
(0.00)b 
0.00 
(0.00)b 
2.84 
(0.11)ab
1.63 
(0.05)a 
3.70 
(0.11)bc
4.41 
(0.16)b 
1.66 
(0.02)a 
13.35 
(5.08)b 
5.11 
(6.05)a 
44.89 
(17.58)bc
2.54 
(0.08)b 
13.22 
(5.83)a 
4.69 
(5.91)b 
3 
5.88 
(1.58)a 
1.14 
(0.07)b 
0.72 
(0.06)b 
1.71 
(0.14)a 
1.65 
(0.86)c 
8.99 
(0.76)a 
1.40 
(0.12)a 
29.23 
(2.43)ab 
1.07 
(0.49)a 
13.29 
(1.17)c 
25.66 
(2.20)a 
3.37 
(0.80)a 
0.97 
(0.54)b 
a,b,c Means within same column followed by different superscripts are significantly different (P<0.05). 
* Also parts per million (PPM) in cheese wet basis. 
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Table 4.30:  Means and standard deviations of main free fatty acids in treated samples of cheese with γ-Oryzanol at different stages of 
maturation. 
 
Free fatty acid (mg/Kg)* 
Month 
C4:0      C6:0         C8:0       C10:0     C12:0      C14:0      C14:1      C16:0      C16:1      C18:0       C18:1     C18:2      C18:3 
0 
0.00 
(0.00)b 
10.28 
(1.65)a 
3.67 
(0.09)b 
2.30 
(0.17)a 
5.08 
(0.11)a 
12.92 
(2.64)a 
1.76 
(0.30)a 
25.39 
(0.26)a 
0.04 
(0.01)c 
85.24 
(2.67)a 
3.08 
(0.78)a 
2.98 
(0.30)b 
4.99 
(2.53)a 
1 
0.00 
(0.00)b 
37.82 
(26.40)a 
5.24 
(0.44)a 
1.39 
(1.88)a 
5.37 
(1.06)a 
6.49 
(0.97)b 
0.25 
(0.06)b 
24.64 
(4.42)ab 
1.24 
(0.46)ab
81.11 
(19.11)a 
4.12 
(1.22)a 
2.06 
(0.51)b 
30.04 
(17.34)a
2 
0.00 
(0.00)b 
0.00 
(0.00)a 
2.60 
(0.34)b 
1.50 
(0.15)a 
3.39 
(0.27)a 
4.00 
(0.28)b 
1.64 
(0.29)a 
15.76 
(0.65)b 
0.80 
(0.09)bc
51.57 
(2.88)ab 
17.28 
(21.46)a
16.69 
(5.94)a 
0.46 
(0.00)a 
3 
5.71 
(0.09)a 
1.12 
(0.07)a 
0.71 
(0.04)c 
1.67 
(0.10)a 
3.57 
(0.61)a 
8.70 
(0.45)ab
1.36 
(0.07)a 
27.99 
(1.33)a 
1.82 
(0.08)a 
12.79 
(0.57)b 
24.71 
(1.09)a 
3.32 
(1.20)b 
0.56 
(0.02)a 
a,b,c Means within same column followed by different superscripts are significantly different (P<0.05). 
* Also parts per million (PPM) in cheese wet basis. 
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APPENDIX B. CONSENT FORM FOR CONSUMER STUDY 
RESEARCH CONSENT FORM 
 
I, _____________________, agree to participate in the research entitled “Sensory Difference and 
Consumer Acceptance of Cheddar Cheese,” which is being conducted by Witoon 
Prinyawiwatkul of the Department of Food Science at Louisiana State University, phone number 
(225)578-5188. 
 
I understand that participation is entirely voluntary and whether or not I participate will not 
affect how I am treated on my job. I can withdraw my consent at any time without penalty or loss 
of benefits to which I am otherwise entitled and have the results of the participation returned to 
me, removed from the experimental records, or destroyed. One hundred consumers will 
participate in this research. For this particular research, about 30-35 min participation will be 
required for each consumer. 
 
The following points have been explained to me: 
 
1. In any case, it is my responsibility to report prior participation to the investigators any 
allergies I may have.  
 
2. The reason for the research is to gather information on consumer sensory acceptability of 
cheddar cheese containing oryzanol (rice bran component). The benefit that I may expect 
from it is a satisfaction that I have contributed to solution and evaluation of problems relating 
to such examinations. 
 
3. The procedures are as follows: One control and two coded samples will be placed in front of 
me, and I will evaluate them by normal standard methods and indicate my evaluation on 
score sheets. All procedures are standard methods as published by the American Society for 
Testing and Materials and the Sensory Evaluation Division of the Institute of Food 
Technologists. 
 
4. Participation entails minimal risk: The only risk which can be envisioned is that of an allergic 
reaction to cheese and rice products.  However, because it is known to me beforehand that 
the foods to be tested contain common food ingredients, the situation can normally be 
avoided. 
 
5. The results of this study will not be released in any individual identifiable form without my 
prior consent unless required by law. 
 
6. The investigator will answer any further questions about the research, either now or during 
the course of the project. 
 
The study has been discussed with me, and all of my questions have been answered. I understand 
that additional questions regarding the study should be directed to the investigators listed above. 
In addition, I understand the research at Louisiana State University AgCenter that involves 
human participation is carried out under the oversight of the Institutional Review Board. 
Questions or problems regarding these activities should be addressed to Dr. David Morrison, 
Assistant Vice Chancellor of LSU AgCenter at 578-8236. I agree with the terms above. 
 
_______________________________  ________________________________ 
Signature of Investigator    Signature of Participant 
 
Date: __________________________  Witness: _________________________ 
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APPENDIX C. QUESTIONNAIRE FOR CONSUMER STUDY 
DEMOGRAPHIC SURVEY:  All information collected will not be identified with your name. 
 
1.  What is your age group?  (Please check one) 
 
18-24 years____  25-34 years____  35-44 years_______ 
45-54 years____  55-64 years____  Over 64 years______ 
 
2.  What is your gender?  Male____________   Female_____________ 
 
3.  Which do you consider yourself to be?  (Please check one) 
 
African-American___________ Hispanic/Spanish______________ Other (Please specify) 
Asian-American___________ White (Caucasian)_____________ _________________ 
Asian_____________ 
 
4.  Level of education?  (Please check one) 
 
Less than high school_____     Some college_____  Graduate (M.S., M.A., Ph.D., Ed.)______ 
                High school_____        Completed college_____ 
 
5.  Which of these categories best describes your gross 2003 household income?  (Please check one) 
 
      Under $9,999______ $10,000 - 19,999____  $20,000 – 29,999____ $30,000 – 39,999____ 
$40,000 – 49,999______ $50,000 – 59,999____ $60,000 – 69,999____ $70,000 – 79,999____ 
$80,000 – 89,999______  $90,000 – 99,999____ Over $100,000______ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 129
SAMPLE No.  _705____ 
 
Please evaluate the following attributes of this cheddar cheese. 
 
1.  How would you rate the OVERALL APPEARANCE of this product? 
  Dislike          Dislike            Dislike        Dislike      Neither Like      Like           Like              Like              Like 
Extremely    Very much    Moderately    Slightly       nor Dislike     Slightly    Moderately   Very much    Extremely 
    [   ]         [   ]                  [   ]             [   ]                [   ]                [   ]             [   ]                [   ]               [   ] 
      1                    2                      3                4                    5                    6                7                    8                   9  
 
2.  How would you rate the SMOOTHNESS of COLOR (yellowness) of this product? 
  Dislike          Dislike            Dislike        Dislike      Neither Like      Like           Like              Like              Like 
Extremely    Very much    Moderately    Slightly       nor Dislike     Slightly    Moderately   Very much    Extremely 
    [   ]         [   ]                  [   ]             [   ]                [   ]                [   ]             [   ]                [   ]                [   ] 
      1                    2                      3                4                    5                    6                7                    8                    9 
 
3.  How would you rate the ODOR/AROMA of this product? 
  Dislike          Dislike            Dislike        Dislike      Neither Like      Like           Like              Like              Like 
Extremely    Very much    Moderately    Slightly       nor Dislike     Slightly    Moderately   Very much    Extremely 
    [   ]         [   ]                  [   ]             [   ]                [   ]                [   ]             [   ]                [   ]                [   ] 
      1                    2                      3                4                    5                    6                7                    8                    9  
 
4.  How would you rate the TASTE of this product? 
  Dislike          Dislike            Dislike        Dislike      Neither Like      Like           Like              Like              Like 
Extremely    Very much    Moderately    Slightly       nor Dislike     Slightly    Moderately   Very much    Extremely 
    [   ]         [   ]                  [   ]             [   ]                [   ]                [   ]             [   ]                [   ]                [   ] 
      1                    2                      3                4                    5                    6                7                    8                    9  
 
5. How would you rate the OVERALL TEXTURE/MOUTHFEEL of this product? 
  Dislike          Dislike            Dislike        Dislike      Neither Like      Like           Like              Like              Like 
Extremely    Very much    Moderately    Slightly       nor Dislike     Slightly    Moderately   Very much    Extremely 
    [   ]         [   ]                  [   ]             [   ]                [   ]                [   ]             [   ]                [   ]                [   ] 
      1                    2                      3                4                    5                    6                7                    8                    9  
6.  Did you detect undesirable bitterness aftertaste?  YES  [   ]           NO  [   ] 
 
7.  Please rate your OVERALL LIKING of this product? 
  Dislike          Dislike            Dislike        Dislike      Neither Like      Like           Like              Like              Like 
Extremely    Very much    Moderately    Slightly       nor Dislike     Slightly    Moderately   Very much    Extremely 
    [   ]         [   ]                  [   ]             [   ]                [   ]                [   ]             [   ]                [   ]                [   ] 
      1                    2                      3                4                    5                    6                7                    8                    9  
8.  Is this product ACCEPTABLE?         YES  [   ]  NO  [   ] 
9.  Would you BUY this product if it were commercially available?           YES  [   ] NO  [   ] 
10.  Would you BUY this product if it contained oryzanol, an antioxidant and potential cholesterol reducing compound from rice 
bran? 
            YES  [   ] NO  [   ] 
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SAMPLE No.  _485____ 
 
Please evaluate the following attributes of this cheddar cheese. 
 
1.  How would you rate the OVERALL APPEARANCE of this product? 
  Dislike          Dislike            Dislike        Dislike      Neither Like      Like           Like              Like              Like 
Extremely    Very much    Moderately    Slightly       nor Dislike     Slightly    Moderately   Very much    Extremely 
    [   ]         [   ]                  [   ]             [   ]                [   ]                [   ]             [   ]                [   ]               [   ] 
      1                    2                      3                4                    5                    6                7                    8                   9  
 
2.  How would you rate the SMOOTHNESS of COLOR (yellowness) of this product? 
  Dislike          Dislike            Dislike        Dislike      Neither Like      Like           Like              Like              Like 
Extremely    Very much    Moderately    Slightly       nor Dislike     Slightly    Moderately   Very much    Extremely 
    [   ]         [   ]                  [   ]             [   ]                [   ]                [   ]             [   ]                [   ]                [   ] 
      1                    2                      3                4                    5                    6                7                    8                    9 
 
3.  How would you rate the ODOR/AROMA of this product? 
  Dislike          Dislike            Dislike        Dislike      Neither Like      Like           Like              Like              Like 
Extremely    Very much    Moderately    Slightly       nor Dislike     Slightly    Moderately   Very much    Extremely 
    [   ]         [   ]                  [   ]             [   ]                [   ]                [   ]             [   ]                [   ]                [   ] 
      1                    2                      3                4                    5                    6                7                    8                    9  
 
4.  How would you rate the TASTE of this product? 
  Dislike          Dislike            Dislike        Dislike      Neither Like      Like           Like              Like              Like 
Extremely    Very much    Moderately    Slightly       nor Dislike     Slightly    Moderately   Very much    Extremely 
    [   ]         [   ]                  [   ]             [   ]                [   ]                [   ]             [   ]                [   ]                [   ] 
      1                    2                      3                4                    5                    6                7                    8                    9  
 
5. How would you rate the OVERALL TEXTURE/MOUTHFEEL of this product? 
  Dislike          Dislike            Dislike        Dislike      Neither Like      Like           Like              Like              Like 
Extremely    Very much    Moderately    Slightly       nor Dislike     Slightly    Moderately   Very much    Extremely 
    [   ]         [   ]                  [   ]             [   ]                [   ]                [   ]             [   ]                [   ]                [   ] 
      1                    2                      3                4                    5                    6                7                    8                    9  
6.  Did you detect undesirable bitterness aftertaste?  YES  [   ]           NO  [   ] 
 
7.  Please rate your OVERALL LIKING of this product? 
  Dislike          Dislike            Dislike        Dislike      Neither Like      Like           Like              Like              Like 
Extremely    Very much    Moderately    Slightly       nor Dislike     Slightly    Moderately   Very much    Extremely 
    [   ]         [   ]                  [   ]             [   ]                [   ]                [   ]             [   ]                [   ]                [   ] 
      1                    2                      3                4                    5                    6                7                    8                    9  
8.  Is this product ACCEPTABLE?         YES  [   ]  NO  [   ] 
9.  Would you BUY this product if it were commercially available?           YES  [   ] NO  [   ] 
10.  Would you BUY this product if it contained oryzanol, an antioxidant and potential cholesterol reducing compound from rice 
bran? 
            YES  [   ] NO  [   ] 
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Part I: VISUAL.  Please evaluate each cheddar cheese sample by LOOKING and comparing it with the labeled 
CONTROL sample. 
 
OVERALL APPEARANCE 
Sample ID Same 
I am sure 
Same 
I am not sure 
Different 
I am not sure 
Different 
I am sure 
705     
485     
 
OVERALL COLOR 
Sample ID Same 
I am sure 
Same 
I am not sure 
Different 
I am not sure 
Different 
I am sure 
705     
485     
 
YELLOWNESS 
Sample ID More 
I am sure 
More  
I am not sure 
Same 
I am not sure 
Same 
I am sure 
Less 
I am sure 
Less 
I am not sure 
705       
485       
 
 
Part II: ODOR.  Please evaluate each cheddar cheese sample by SMELLING and comparing it with the labeled 
CONTROL sample. 
 
ODOR 
Sample ID Same 
I am sure 
Same 
I am not sure 
Different 
I am not sure 
Different 
I am sure 
705     
485     
 
 
Part III: TASTE AND TEXTURE.  Please evaluate each cheddar cheese sample by TASTING and CHEWING 
and comparing it with the labeled CONTROL sample. 
 
TASTE 
Sample ID Same 
I am sure 
Same 
I am not sure 
Different 
I am not sure 
Different 
I am sure 
705     
485     
 
 
OVERALL TEXTURE 
Sample ID Same 
I am sure 
Same 
I am not sure 
Different 
I am not sure 
Different 
I am sure 
705     
485     
 
HARDNESS 
Sample ID More 
I am sure 
More  
I am not sure 
Same 
I am not sure 
Same 
I am sure 
Less 
I am sure 
Less 
I am not sure 
705       
485       
 
CHEWINESS 
Sample ID More 
I am sure 
More  
I am not sure 
Same 
I am not sure 
Same 
I am sure 
Less 
I am sure 
Less 
I am not sure 
705       
485       
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APPENDIX D. SAS CODES 
a. COLOR AND TEXTURE 
dm 'log;clear;output;clear'; 
data one; 
input sample $ rep month hard cohes adhes gummi chewi spring resil 
 LL aa bb cc hh; 
datalines; 
inserted data; 
proc sort; by sample month; 
proc means mean std n maxdec=2;by sample month; 
var hard--hh;  
proc sort; by sample; 
proc glm;by sample; 
class month; 
model hard--hh = month; 
means month/tukey lines; 
proc sort; by month; 
proc ttest; by month; 
**//independent ttest; 
class sample; 
var hard--hh; 
run; 
 
b. MICROBIAL GROWTH 
dm 'log;clear;output;clear'; 
data one; 
input sample $ rep month logAPC logCOL; 
datalines; 
inserted data; 
proc sort; by sample month; 
proc means mean std n maxdec=2;by sample month; 
var logAPC--logCOL;  
proc sort; by sample; 
proc glm; by sample; 
class month; 
model logAPC--logCOL = month; 
means month/tukey lines; 
proc sort; by month; 
proc ttest; by month; 
**//independent ttest; 
class sample; 
var logAPC--logCOL; 
run; 
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c. AROMA 
dm 'log;clear;output;clear'; 
data one; 
input sample $ month peak1 peak2 peak3 peak4 peak5 peak6; 
datalines; 
inserted data; 
proc sort; by sample month; 
proc means mean std n maxdec=2;by sample month; 
var peak1--peak6;  
proc sort; by sample; 
proc glm; by sample; 
class month; 
model peak1--peak6 = month; 
means month/tukey lines; 
proc sort; by month; 
proc ttest; by month; 
**//independent ttest; 
class sample; 
var peak1--peak6; 
run; 
 
d. ORYZANOL RETENTION 
dm 'log;clear;output;clear'; 
data one; 
input sample $ rep month oryzanol; 
datalines; 
inserted data; 
proc sort; by month; 
proc means mean std n maxdec=2;by month; 
var oryzanol;  
proc glm; 
class month; 
model oryzanol = month; 
means month/tukey lines; 
run; 
 
e. MOISTURE CONTENT 
dm 'log;clear;output;clear'; 
data one; 
input sample $ rep month moisture; 
datalines; 
inserted data; 
proc sort; by sample month; 
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proc means mean std n maxdec=2;by sample month; 
var moisture;  
proc sort; by sample; 
proc glm; by sample; 
class month; 
model moisture = month; 
means month/tukey lines; 
proc sort; by month; 
proc ttest; by month; 
**//independent ttest; 
class sample; 
var moisture; 
run; 
 
f. FREE FATTY ACID PROFILE 
dm 'log;clear;output;clear'; 
data one; 
input sample $ rep month C4 C6 C8 C10 C12 C14 C141 C16 
 C161 C18 C181 C182 C183; 
datalines; 
inserted data; 
proc sort; by sample month; 
proc means mean std n maxdec=2;by sample month; 
var C4--C183;  
proc sort; by sample; 
proc glm; by sample; 
class month; 
model C4--C183 = month; 
means month/tukey lines; 
proc sort; by month; 
proc ttest; by month; 
**//independent ttest; 
class sample; 
var C4--C183; 
run; 
 
g. THE MCNEMAR TEST 
dm 'log;clear;output;clear'; 
data one; 
Input sample buy buyif count; 
datalines; 
inserted data; 
run; 
proc freq; weight count; 
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tables buy*buyif/agree; by sample; 
run; 
 
h. CONSUMER ACCEPTANCE (MANOVA, DDA AND LOGISTIC REGRESSION) 
dm 'log;clear;output;clear'; 
data one; 
input consumer sample gender appear color aroma  
taste mouthf bitter olike accept buy buyif; 
datalines; 
inserted data; 
proc sort; by sample; 
proc means mean std n maxdec=2;by sample; 
var appear color aroma taste mouthf olike;  
proc freq; by sample; 
tables bitter accept buy buyif; 
proc anova; 
class sample; 
model appear color aroma taste mouthf olike = sample; 
means sample/tukey lines; 
Proc candisc out=outcan mah; 
class sample; 
var appear color aroma taste mouthf olike; 
Proc logistic data = one; 
model accept = appear color aroma taste mouthf olike; 
Proc logistic data = one; 
model accept = appear; 
Proc logistic data = one; 
model accept = color; 
Proc logistic data = one; 
model accept = aroma; 
Proc logistic data = one; 
model accept = taste; 
Proc logistic data = one; 
model accept = mouthf; 
Proc logistic data = one; 
model accept = olike; 
Proc logistic data = one; 
model buy = appear color aroma taste mouthf olike; 
Proc logistic data = one; 
model buy = appear; 
Proc logistic data = one; 
model buy = color; 
Proc logistic data = one; 
model buy = aroma; 
Proc logistic data = one; 
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model buy = taste; 
Proc logistic data = one; 
model buy = mouthf; 
Proc logistic data = one; 
model buy = olike; 
Proc logistic data = one; 
model buyif = appear color aroma taste mouthf olike; 
Proc logistic data = one; 
model buyif = appear; 
Proc logistic data = one; 
model buyif = color; 
Proc logistic data = one; 
model buyif = aroma; 
Proc logistic data = one; 
model buyif = taste; 
Proc logistic data = one; 
model buyif = mouthf; 
Proc logistic data = one; 
model buyif = olike; 
run; 
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APPENDIX E. CERTIFICATE OF ANALYSIS OF GAMMA-ORYZANOL 
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